Unnamed: 0,datetime,title,source,link
0.0,3/17/2017 1:00:00 PM,"How These Generic Drugs Stocks are Faring? -- Neurocrine Biosciences, Lannett, Rigel Pharma, and Catalent",PR Newswire,/news/stocks/how-these-generic-drugs-stocks-are-faring-neurocrine-biosciences-lannett-rigel-pharma-and-catalent-1001845733
1.0,4/24/2017 12:20:00 PM,"How These Generic Drugs Stocks are Faring? -- Evoke Pharma, Neurocrine Biosciences, Lannett, and Catalent",PR Newswire,/news/stocks/how-these-generic-drugs-stocks-are-faring-evoke-pharma-neurocrine-biosciences-lannett-and-catalent-1001941431
2.0,6/5/2017 12:10:00 PM,"Breakfast Technical Briefing on Generic Drugs Stocks -- Innocoll, Rigel Pharma, Tetraphase Pharma, and Catalent",PR Newswire,/news/stocks/breakfast-technical-briefing-on-generic-drugs-stocks-innocoll-rigel-pharma-tetraphase-pharma-and-catalent-1002066696
3.0,8/30/2017 12:15:00 PM,"Technical Snapshots for These Generic Drugs Stocks -- Allergan, Catalent, Tetraphase Pharma, and pSivida",PR Newswire,/news/stocks/technical-snapshots-for-these-generic-drugs-stocks-allergan-catalent-tetraphase-pharma-and-psivida-1002294148
4.0,9/19/2017 1:40:43 PM,Catalent To Acquire Privately Held Cook Pharmica For $950 Mln Cash - Quick Facts ,RTTNews,/news/stocks/catalent-to-acquire-privately-held-cook-pharmica-for-950-mln-cash-quick-facts-1002382341
5.0,9/20/2017 3:25:00 PM,"Catalent Pharma Solutions, Inc. -- Moody's affirms Catalent's B1 CFR; outlook stable",Moodys,/news/bonds/catalent-pharma-solutions-inc-moody-s-affirms-catalent-s-b1-cfr-outlook-stable-1002387531
6.0,9/27/2017 8:01:55 AM,"AKBA Hits New 52-week High, PMD Launches Hair Test, Mateon Runs Out Of FOCUS ",RTTNews,/news/stocks/akba-hits-new-52-week-high-pmd-launches-hair-test-mateon-runs-out-of-focus-1002621306
7.0,10/4/2017 8:59:00 PM,"Catalent Pharma Solutions, Inc. -- Moody's assigns Ba3 ratings to Catalent's new senior secured credit facilities",Moodys,/news/bonds/catalent-pharma-solutions-inc-moody-s-assigns-ba3-ratings-to-catalent-s-new-senior-secured-credit-facilities-1003015977
8.0,10/10/2017 5:49:00 PM,"Catalent Pharma Solutions, Inc. -- Moody's assigns B3 rating to Catalent's new senior unsecured notes",Moodys,/news/bonds/catalent-pharma-solutions-inc-moody-s-assigns-b3-rating-to-catalent-s-new-senior-unsecured-notes-1003683509
9.0,2/21/2018 9:00:00 AM,Biohaven Announces Exclusive License With Catalent For Zydis® Orally Dissolving Tablet With Small Molecule CGRP Receptor Antagonists,PR Newswire,/news/stocks/biohaven-announces-exclusive-license-with-catalent-for-zydis-orally-dissolving-tablet-with-small-molecule-cgrp-receptor-antagonists-1016547076
10.0,3/1/2018 9:00:00 AM,Biohaven Announces Positive Results From Bioequivalence Study With Sublingual Rimegepant Zydis® Orally Dissolving Tablet,PR Newswire,/news/stocks/biohaven-announces-positive-results-from-bioequivalence-study-with-sublingual-rimegepant-zydis-orally-dissolving-tablet-1017541810
11.0,3/6/2018 9:00:00 AM,Biohaven Enrolls First Patient In Phase 3 Clinical Trial To Evaluate Rimegepant Zydis® ODT In The Acute Treatment Of Migraine,PR Newswire,/news/stocks/biohaven-enrolls-first-patient-in-phase-3-clinical-trial-to-evaluate-rimegepant-zydis-odt-in-the-acute-treatment-of-migraine-1018101386
12.0,5/1/2018 1:49:55 PM,BRIEF-Catalent Reports Q3 Earnings Per Share Of $0.14,Reuters,http://feeds.reuters.com/~r/reuters/companyNews/~3/pkfjeCzLvrk/brief-catalent-reports-q3-earnings-per-share-of-0-14-idUSASC09YK6
13.0,5/15/2018 10:15:00 PM,Biohaven Pharmaceuticals Reports First Quarter 2018 Financial and Recent Business Results,PR Newswire,/news/stocks/biohaven-pharmaceuticals-reports-first-quarter-2018-financial-and-recent-business-results-1024609532
14.0,7/3/2018 9:11:06 AM,Juniper Pharma Agrees To Be Acquired By Catalent For $11.50/shr ,RTTNews,/news/stocks/juniper-pharma-agrees-to-be-acquired-by-catalent-for-11-50-shr-1027337326
15.0,7/3/2018 10:51:13 AM,Catalent to buy Juniper Pharmaceuticals for $11.50 per share,Reuters,http://feeds.reuters.com/~r/reuters/companyNews/~3/xeaf8ZG2-FM/catalent-to-buy-juniper-pharmaceuticals-for-11-50-per-share-idUSL4N1TZ35B
16.0,7/24/2018 10:40:00 PM,"Catalent Pharma Solutions, Inc. -- Moody's: Catalent's plan to use equity offering proceeds for debt repayment is credit positive",Moodys,/news/bonds/catalent-pharma-solutions-inc-moody-s-catalent-s-plan-to-use-equity-offering-proceeds-for-debt-repayment-is-credit-positive-1027396146
17.0,8/6/2018 4:43:00 PM,"Catalent Pharma Solutions, Inc. -- Moody's upgrades Catalent's senior secured ratings to Ba2",Moodys,/news/bonds/catalent-pharma-solutions-inc-moody-s-upgrades-catalent-s-senior-secured-ratings-to-ba2-1027434760
18.0,11/4/2018 3:01:59 PM,Catalent earnings preview: what Wall Street is expecting,Markets Insider Automation,/news/stocks/catalent-q1-earnings-preview-1027688051
19.0,2/3/2019 3:01:40 PM,Catalent earnings: here's what to expect,Markets Insider Automation,/news/stocks/catalent-q2-earnings-preview-stock-1027918662
20.0,4/15/2019 12:08:06 AM,Catalent to buy Paragon Bioservices for $1.2 bln -WSJ,Reuters,http://feeds.reuters.com/~r/reuters/companyNews/~3/5wCgtk2NUuE/catalent-to-buy-paragon-bioservices-for-1-2-bln-wsj-idUSL3N21W0EP
21.0,4/15/2019 1:39:19 AM,UPDATE 1-Catalent to buy Paragon Bioservices for $1.2 bln -WSJ,Reuters,http://feeds.reuters.com/~r/reuters/companyNews/~3/G1mxHlRd_t4/update-1-catalent-to-buy-paragon-bioservices-for-1-2-bln-wsj-idUSL1N21W0A4
22.0,4/15/2019 5:17:33 AM,Catalent to buy Paragon Bioservices for $1.2 billion - WSJ,Reuters,http://feeds.reuters.com/~r/reuters/INbusinessNews/~3/tMsZVVj1_Ew/catalent-to-buy-paragon-bioservices-for-1-2-billion-wsj-idINKCN1RR086
23.0,4/15/2019 6:00:54 AM,WSJ : Catalent To Buy Paragon Bioservices In $1.2 Bln Deal ,RTTNews,/news/stocks/wsj-catalent-to-buy-paragon-bioservices-in-1-2-bln-deal-1028109300
24.0,4/15/2019 1:13:41 PM,Catalent to buy Paragon Bioservices for $1.2 bln,Reuters,http://feeds.reuters.com/~r/reuters/companyNews/~3/BCtv7e2wrBM/catalent-to-buy-paragon-bioservices-for-1-2-bln-idUSL3N21X2O2
25.0,4/15/2019 1:38:55 PM,UPDATE 1-Catalent pushes into gene therapy with $1.2 bln buyout of Paragon Bioservices,Reuters,http://feeds.reuters.com/~r/reuters/companyNews/~3/UddWUKsgp8s/update-1-catalent-pushes-into-gene-therapy-with-1-2-bln-buyout-of-paragon-bioservices-idUSL3N21X2OT
26.0,4/15/2019 2:01:05 PM,Catalent To Acquire Gene Therapy Leader Paragon Bioservices For $1.2 Bln ,RTTNews,/news/stocks/catalent-to-acquire-gene-therapy-leader-paragon-bioservices-for-1-2-bln-1028110588
27.0,4/15/2019 4:59:15 PM,UPDATE 2-Catalent seeks slice of gene therapy market with Paragon buy,Reuters,http://feeds.reuters.com/~r/reuters/companyNews/~3/LfH5qm2wryM/update-2-catalent-seeks-slice-of-gene-therapy-market-with-paragon-buy-idUSL3N21X2OT
28.0,4/15/2019 9:30:29 PM,UPDATE 3-Catalent seeks slice of gene therapy market with Paragon buy,Reuters,http://feeds.reuters.com/~r/reuters/companyNews/~3/HjN5XSkJtEo/update-3-catalent-seeks-slice-of-gene-therapy-market-with-paragon-buy-idUSL3N21X2OT
29.0,4/17/2019 5:36:00 PM,"Catalent Pharma Solutions, Inc. -- Moody's: Catalent's acquisition of Paragon will increase leverage, a credit negative",Moodys,/news/bonds/catalent-pharma-solutions-inc-moody-s-catalent-s-acquisition-of-paragon-will-increase-leverage-a-credit-negative-1028119200
30.0,4/17/2019 10:04:00 PM,"Catalent Pharma Solutions, Inc. -- Moody's announces completion of a periodic review of ratings of Catalent Pharma Solutions, Inc.",Moodys,/news/bonds/catalent-pharma-solutions-inc-moody-s-announces-completion-of-a-periodic-review-of-ratings-of-catalent-pharma-solutions-inc-1028119829
31.0,5/5/2019 3:01:52 PM,Catalent earnings preview: what Wall Street is expecting,Markets Insider Automation,/news/stocks/catalent-stock-q3-earnings-preview-1028168425
32.0,5/9/2019 8:17:00 PM,"Catalent Pharma Solutions, Inc. -- Moody's downgrades Catalent's Senior Secured Rating to Ba3, affirms B1 CFR rating. The outlook remains stable",Moodys,/news/bonds/catalent-pharma-solutions-inc-moody-s-downgrades-catalent-s-senior-secured-rating-to-ba3-affirms-b1-cfr-rating-the-outlook-remains-stable-1028187652
33.0,5/9/2019 8:19:00 PM,"Catalent Pharma Solutions, Inc. -- Moody's downgrades Catalent's senior secured rating to Ba3, affirms B1 CFR rating; the outlook remains stable",Moodys,/news/bonds/catalent-pharma-solutions-inc-moody-s-downgrades-catalent-s-senior-secured-rating-to-ba3-affirms-b1-cfr-rating-the-outlook-remains-stable-1028187662
34.0,6/19/2019 1:17:07 PM,Catalent To Buy Bristol-Myers Squibb's Manufacturing Facility In Italy ,RTTNews,/news/stocks/catalent-to-buy-bristol-myers-squibb-s-manufacturing-facility-in-italy-1028290995
35.0,6/24/2019 8:02:00 PM,"Catalent Pharma Solutions, Inc. -- Moody's assigns B3 rating to Catalent's notes offering",Moodys,/news/bonds/catalent-pharma-solutions-inc-moody-s-assigns-b3-rating-to-catalent-s-notes-offering-1028303076
36.0,8/21/2019 4:55:36 PM,"10 Small-Cap, Up-And-Coming Stocks to Keep on Your Radar",InvestorPlace,/news/stocks/10-small-cap-up-and-coming-stocks-to-keep-on-your-radar-1028382997
37.0,8/25/2019 3:01:28 PM,Catalent is about to announce its earnings — here's what Wall Street expects,Markets Insider Automation,/news/stocks/catalent-stock-price-q4-earnings-preview-1028471382
38.0,2/2/2020 3:01:24 PM,Here's what Wall Street expects from Catalent's earnings,Markets Insider Automation,/news/stocks/catalent-stock-quarter-earnings-preview-q2-1028865676
39.0,2/3/2020 1:57:09 PM,Catalent To Buy MaSTherCell Global - Quick Facts ,RTTNews,/news/stocks/catalent-to-buy-masthercell-global-quick-facts-1028867432
40.0,2/3/2020 4:46:54 PM,Stock Alert: Catalent Inc. (CTLT) Shares Hit 52-Week High ,RTTNews,/news/stocks/stock-alert-catalent-inc-ctlt-shares-hit-52-week-high-1028868535
41.0,2/19/2020 10:15:00 PM,"Catalent Pharma Solutions, Inc. -- Moody's assigns B3 rating to Catalent's notes offering",Moodys,/news/bonds/catalent-pharma-solutions-inc-moody-s-assigns-b3-rating-to-catalent-s-notes-offering-1028920984
42.0,2/28/2020 10:31:00 PM,"Catalent Pharma Solutions, Inc. -- Moody's upgrades Catalent's senior secured rating to Ba2, affirms B1 CFR; the outlook remains stable",Moodys,/news/bonds/catalent-pharma-solutions-inc-moody-s-upgrades-catalent-s-senior-secured-rating-to-ba2-affirms-b1-cfr-the-outlook-remains-stable-1028951218
43.0,3/6/2020 5:56:00 PM,"Catalent Pharma Solutions, Inc. -- Moody's announces completion of a periodic review of ratings of Catalent Pharma Solutions, Inc.",Moodys,/news/bonds/catalent-pharma-solutions-inc-moody-s-announces-completion-of-a-periodic-review-of-ratings-of-catalent-pharma-solutions-inc-1028972751
44.0,5/4/2020 3:01:31 PM,Catalent earnings preview: what Wall Street is expecting,Markets Insider Automation,/news/stocks/catalent-stock-quarter-earnings-preview-q3-1029160413
45.0,5/9/2020 11:22:39 PM,"Focusing on vaccine, Pfizer turns to outsourcing",Seeking Alpha,https://seekingalpha.com/news/3572399-focusing-on-vaccine-pfizer-turns-to-outsourcing?utm_source=markets.businessinsider.com&utm_medium=referral
46.0,6/15/2020 1:46:10 PM,AstraZeneca picks Catalent for packaging potential COVID-19 vaccine,Reuters,http://feeds.reuters.com/~r/reuters/companyNews/~3/_0a7VYax6wo/astrazeneca-picks-catalent-for-packaging-potential-covid-19-vaccine-idUSL4N2DS2XI
47.0,6/15/2020 1:54:02 PM,Catalent Signs Deal With AstraZeneca To Manufacture COVID-19 Vaccine Candidate ,RTTNews,/news/stocks/catalent-signs-deal-with-astrazeneca-to-manufacture-covid-19-vaccine-candidate-1029307815
48.0,6/25/2020 2:20:42 PM,"Moderna, Catalent Collaborate For Manufacturing Of COVID-19 Vaccine Candidate ",RTTNews,/news/stocks/moderna-catalent-collaborate-for-manufacturing-of-covid-19-vaccine-candidate-1029341883
49.0,7/10/2020 6:06:00 PM,Why Investors Should Take Another Look at Moderna’s Many Advantages,InvestorPlace,/news/stocks/why-investors-should-take-another-look-at-modernas-many-advantages-1029384587
50.0,7/16/2020 1:37:24 PM,"Catalent, Humanigen Expand Relationship To Make COVID-19 Therapeutic Candidate Lenzilumab ",RTTNews,/news/stocks/catalent-humanigen-expand-relationship-to-make-covid-19-therapeutic-candidate-lenzilumab-1029401058
51.0,8/24/2020 2:26:48 PM,Catalent's Maryland Facility To Provide Manufacturing Support For AstraZeneca's COVID-19 Vaccine ,RTTNews,/news/stocks/catalent-s-maryland-facility-to-provide-manufacturing-support-for-astrazeneca-s-covid-19-vaccine-1029527527
52.0,8/30/2020 3:01:23 PM,Catalent earnings preview: what Wall Street is expecting,Markets Insider Automation,/news/stocks/catalent-q4-quarterly-earnings-preview-1029546183
53.0,8/31/2020 4:09:36 PM,Stock Alert: Catalent Shares Up Over 3% On Upbeat Q4 ,RTTNews,/news/stocks/stock-alert-catalent-shares-up-over-3-on-upbeat-q4-1029548485
54.0,9/4/2020 9:28:54 PM,Tesla -4.3% as S&P 500 rebalance skips automaker,Seeking Alpha,https://seekingalpha.com/news/3611885-teslaminus-4_3-s-and-p-500-rebalance-skips-automaker?utm_source=markets.businessinsider.com&utm_medium=referral
55.0,11/2/2020 3:01:54 PM,What Wall Street expects from Catalent's earnings,Markets Insider Automation,/news/stocks/catalent-q1-earnings-preview-1029753481
56.0,11/2/2020 5:36:54 PM,Notable earnings before Tuesday's open,Seeking Alpha,https://seekingalpha.com/news/3629754-notable-earnings-tuesdays-open?utm_source=markets.businessinsider.com&utm_medium=referral
57.0,11/2/2020 6:00:30 PM,Catalent Q1 2021 Earnings Preview,Seeking Alpha,https://seekingalpha.com/news/3629776-catalent-q1-2021-earnings-preview?utm_source=markets.businessinsider.com&utm_medium=referral
58.0,11/3/2020 12:21:40 PM,"Catalent EPS beats by $0.06, beats on revenue",Seeking Alpha,https://seekingalpha.com/news/3630262-catalent-eps-beats-0_06-beats-on-revenue?utm_source=markets.businessinsider.com&utm_medium=referral
59.0,11/3/2020 2:14:02 PM,Biologics segment boost Catalent's FQ1 results; raises 2021 outlook,Seeking Alpha,https://seekingalpha.com/news/3630349-biologics-segment-boost-catalents-fq1-results-raises-2021-outlook?utm_source=markets.businessinsider.com&utm_medium=referral
60.0,11/10/2020 8:35:00 AM,"ARNA Falls Short Of ADVICE, PFE's COVID-19 Vaccine Shows 90% Efficacy, SUPN Hit By Double Whammy ",RTTNews,/news/stocks/arna-falls-short-of-advice-pfe-s-covid-19-vaccine-shows-90-efficacy-supn-hit-by-double-whammy-1029784994
61.0,11/13/2020 8:49:32 PM,"Shell Asset adds some gold stakes, Tesla, cuts Western Digital, buys StoneX",Seeking Alpha,https://seekingalpha.com/news/3636286-shell-asset-adds-gold-stakes-tesla-cuts-western-digital-buys-stonex?utm_source=markets.businessinsider.com&utm_medium=referral
62.0,11/18/2020 10:22:00 PM,"Catalent Pharma Solutions, Inc. -- Moody's upgrades Catalent's CFR to Ba3; outlook stable",Moodys,/news/bonds/catalent-pharma-solutions-inc-moody-s-upgrades-catalent-s-cfr-to-ba3-outlook-stable-1029818083
63.0,12/20/2020 2:42:19 PM,Small contractors play pivotal role on vaccine supply chain,Seeking Alpha,https://seekingalpha.com/news/3646033-small-contractors-play-pivotal-role-on-vaccine-supply-chain?utm_source=markets.businessinsider.com&utm_medium=referral
64.0,12/20/2020 2:42:19 PM,Smaller contractors play pivotal role in vaccine supply chain,Seeking Alpha,https://seekingalpha.com/news/3646033-smaller-contractors-play-pivotal-role-in-vaccine-supply-chain?utm_source=markets.businessinsider.com&utm_medium=referral
65.0,1/1/2021 12:30:56 AM,"Tesla leads list of 2020's biggest winners on both S&P 500, Nasdaq 100",Seeking Alpha,https://seekingalpha.com/news/3648158-tesla-leads-list-of-2020s-biggest-winners-on-s-and-p-500-nasdaq-100?utm_source=markets.businessinsider.com&utm_medium=referral
66.0,1/11/2021 8:19:16 PM,"Catalent initiated with Strong Buy at CFRA; Biologics, the largest contributor",Seeking Alpha,https://seekingalpha.com/news/3650458-catalent-initiated-strong-buy-cfra-biologics-largest-contributor?utm_source=markets.businessinsider.com&utm_medium=referral
67.0,1/13/2021 1:25:38 PM,"The Daily Biotech Pulse: Bausch Health Issues Positive Pre-Announcement, Acorda Streamlines Operations",Benzinga,/news/stocks/the-daily-biotech-pulse-bausch-health-issues-positive-pre-announcement-acorda-streamlines-operations-1029963908
68.0,1/13/2021 1:41:05 PM,"Acorda Therapeutics to sell Inbrija manufacturing operations for $80M, reduces headcount by 16%, shares up 65%",Seeking Alpha,https://seekingalpha.com/news/3651051-acorda-therapeutics-to-sell-inbrija-manufacturing-operations-for-80m-reduces-headcount-16?utm_source=markets.businessinsider.com&utm_medium=referral
69.0,1/30/2021 7:19:15 PM,"The Week Ahead In Biotech: Merck, Pfizer In Earnings Mix, Plus Adamas, Mallinckrodt FDA Decisions, IPOs And More",Benzinga,/news/stocks/the-week-ahead-in-biotech-merck-pfizer-in-earnings-mix-plus-adamas-mallinckrodt-fda-decisions-ipos-and-more-1030022250
70.0,1/31/2021 3:01:27 PM,Catalent earnings: here's what Wall Street expects,Markets Insider Automation,/news/stocks/catalent-stock-quarter-earnings-preview-q2-1030022964
71.0,2/1/2021 5:19:44 PM,Notable earnings before Tuesday's open,Seeking Alpha,https://seekingalpha.com/news/3656739-notable-earnings-before-tuesdays-open?utm_source=markets.businessinsider.com&utm_medium=referral
72.0,2/1/2021 5:29:14 PM,Catalent FQ2 2021 Earnings Preview,Seeking Alpha,https://seekingalpha.com/news/3656746-catalent-fq2-2021-earnings-preview?utm_source=markets.businessinsider.com&utm_medium=referral
73.0,2/2/2021 12:17:28 PM,"Catalent EPS beats by $0.07, beats on revenue",Seeking Alpha,https://seekingalpha.com/news/3657111-catalent-eps-beats-0_07-beats-on-revenue?utm_source=markets.businessinsider.com&utm_medium=referral
74.0,2/2/2021 2:05:48 PM,"The Daily Biotech Pulse: Vertex, Pfizer Earnings, Tiziana COVID-19 Vaccine Data, Decision Day For Mallinckrodt's Burn Treatment",Benzinga,/news/stocks/the-daily-biotech-pulse-vertex-pfizer-earnings-tiziana-covid-19-vaccine-data-decision-day-for-mallinckrodt-s-burn-treatment-1030032611
75.0,2/3/2021 1:31:17 PM,"The Daily Biotech Pulse: Amgen Earnings, GSK-CureVac Vaccine Collaboration, Mallinckrodt FDA Decision",Benzinga,/news/stocks/the-daily-biotech-pulse-amgen-earnings-gsk-curevac-vaccine-collaboration-mallinckrodt-fda-decision-1030037844
76.0,2/3/2021 10:29:00 PM,"Catalent Pharma Solutions, Inc. -- Moody's announces completion of a periodic review of ratings of Catalent Pharma Solutions, Inc.",Moodys,/news/bonds/catalent-pharma-solutions-inc-moody-s-announces-completion-of-a-periodic-review-of-ratings-of-catalent-pharma-solutions-inc-1030040546
77.0,2/10/2021 1:44:56 PM,Catalent to raise $475M through unsecured debt,Seeking Alpha,https://seekingalpha.com/news/3660520-catalent-to-raise-475m-through-unsecured-debt?utm_source=markets.businessinsider.com&utm_medium=referral
78.0,2/10/2021 8:25:00 PM,"Catalent Pharma Solutions, Inc. -- Moody's assigns B1 rating to Catalent's notes offering",Moodys,/news/bonds/catalent-pharma-solutions-inc-moody-s-assigns-b1-rating-to-catalent-s-notes-offering-1030068483
79.0,2/17/2021 1:26:55 PM,"The Daily Biotech Pulse: Novartis Funding For Gene Therapy Research, Priority Review For Amgen Cancer Drug, Pfizer-BioNTech Vaccine Supply Deal",Benzinga,/news/stocks/the-daily-biotech-pulse-novartis-funding-for-gene-therapy-research-priority-review-for-amgen-cancer-drug-pfizer-biontech-vaccine-supply-deal-1030091631
80.0,2/24/2021 7:27:50 PM,Intra-Cellular expands pipeline with a new therapy targeting dementia,Seeking Alpha,https://seekingalpha.com/news/3665788-intra-cellular-expands-pipeline-with-a-new-therapy-targeting-dementia?utm_source=markets.businessinsider.com&utm_medium=referral
81.0,2/28/2021 3:04:59 AM,JNJ to deliver fewer COVID-19 vaccine doses amid production problems: FT,Seeking Alpha,https://seekingalpha.com/news/3667406-jnj-to-deliver-fewer-covid-19-vaccine-doses-amid-production-problems-ft?utm_source=markets.businessinsider.com&utm_medium=referral
82.0,3/3/2021 2:05:48 PM,Novavax taps Polish biotech firm Mabion for COVID-19 vaccine production,Seeking Alpha,https://seekingalpha.com/news/3668722-novavax-taps-mabion-for-covid-19-vaccine-production?utm_source=markets.businessinsider.com&utm_medium=referral
83.0,3/17/2021 3:55:14 PM,7 Growth Stocks With Compelling Stories,InvestorPlace,/news/stocks/7-growth-stocks-with-compelling-stories-1030220806
84.0,3/22/2021 11:28:21 AM,Cybin inks drug development agreement with Catalent,Seeking Alpha,https://seekingalpha.com/news/3674682-cybin-inks-drug-development-agreement-with-catalent?utm_source=markets.businessinsider.com&utm_medium=referral
85.0,3/23/2021 6:34:36 PM,JNJ COVID-19 vaccine deliveries to rise as Catalent facility in Indiana gets FDA nod,Seeking Alpha,https://seekingalpha.com/news/3675408-jnj-covid-19-vaccine-deliveries-to-rise-as-catalent-facility-in-indiana-gets-fda-nod?utm_source=markets.businessinsider.com&utm_medium=referral
86.0,4/6/2021 10:51:37 AM,Moderna to double its COVID-19 vaccine output at Catalent facility,Seeking Alpha,https://seekingalpha.com/news/3679383-moderna-to-double-its-covid-19-vaccine-output-at-catalent-facility?utm_source=markets.businessinsider.com&utm_medium=referral
87.0,4/6/2021 3:19:38 PM,"Moderna, Catalent Expand Collaboration For Vial Filling Of COVID-19 Vaccine & Clinical Portfolio ",RTTNews,/news/stocks/moderna-catalent-expand-collaboration-for-vial-filling-of-covid-19-vaccine-clinical-portfolio-1030277380
88.0,4/11/2021 3:38:21 PM,Healthcare momentum struggling with UnitedHealth set to report: Sector Watch,Seeking Alpha,https://seekingalpha.com/news/3680852-healthcare-stocks-momentum-stalling?utm_source=markets.businessinsider.com&utm_medium=referral
89.0,4/21/2021 7:35:11 PM,"UBS bullish on Q1 growth for life sciences & diagnostic tools; picks IQVIA, Catalent and Avantor as top ideas",Seeking Alpha,https://seekingalpha.com/news/3684160-ubs-bullish-on-q1-growth-for-life-sciences-diagnostic-tools-cites-perkinelmer-guidance?utm_source=markets.businessinsider.com&utm_medium=referral
90.0,4/27/2021 3:52:49 PM,Catalent to manufacture AavantiBio’s experimental gene therapies,Seeking Alpha,https://seekingalpha.com/news/3686189-catalent-to-manufacture-aavantibios-experimental-gene-therapies?utm_source=markets.businessinsider.com&utm_medium=referral
91.0,5/1/2021 7:19:25 PM,"Week Ahead In Biotech (May 2-8): ChemoCentryx Adcom, Ophthalmology Conference Presentations, Earnings Deluge",Benzinga,/news/stocks/week-ahead-in-biotech-may-2-8-chemocentryx-adcom-ophthalmology-conference-presentations-earnings-deluge-1030373608
92.0,5/2/2021 3:01:32 PM,Here's what Wall Street expects from Catalent's earnings,Markets Insider Automation,/news/stocks/catalent-q3-earnings-preview-1030374696
93.0,5/3/2021 5:04:25 PM,Notable earnings before Tuesday's open,Seeking Alpha,https://seekingalpha.com/news/3689391-notable-earnings-tuesdays-open?utm_source=markets.businessinsider.com&utm_medium=referral
94.0,5/3/2021 5:19:28 PM,Catalent FQ3 2021 Earnings Preview,Seeking Alpha,https://seekingalpha.com/news/3689406-catalent-fq3-2021-earnings-preview?utm_source=markets.businessinsider.com&utm_medium=referral
95.0,5/4/2021 11:15:00 AM,"Catalent EPS beats by $0.07, beats on revenue",Seeking Alpha,https://seekingalpha.com/news/3690005-catalent-eps-beats-0_07-beats-on-revenue?utm_source=markets.businessinsider.com&utm_medium=referral
96.0,5/4/2021 2:10:21 PM,"The Daily Biotech Pulse: Vaxart Rebounds On Strong Vaccine Data, Pfizer's Beat-And-Raise Quarter, BioLineRx Data",Benzinga,/news/stocks/the-daily-biotech-pulse-vaxart-rebounds-on-strong-vaccine-data-pfizer-s-beat-and-raise-quarter-biolinerx-data-1030383815
97.0,5/15/2021 10:45:29 PM,The 'new momentum' stocks to watch: Alpha Tactics,Seeking Alpha,https://seekingalpha.com/news/3696874-the-new-momentum-stocks-to-watch?utm_source=markets.businessinsider.com&utm_medium=referral
98.0,6/7/2021 9:25:20 PM,5 Top ETFs With Exposure To Biogen,Benzinga,/news/etf/5-top-etfs-with-exposure-to-biogen-1030500950
99.0,6/25/2021 2:15:29 PM,JNJ COVID-19 vaccine supplies in Europe to rise with approval of production site,Seeking Alpha,https://seekingalpha.com/news/3710157-jnj-covid-19-vaccine-supplies-in-europe-to-rise-with-approval-of-production-site?utm_source=markets.businessinsider.com&utm_medium=referral
100.0,6/27/2021 6:13:46 PM,What the qaunts want: here are the top 10 stocks: Sector Watch,Seeking Alpha,https://seekingalpha.com/news/3710320-what-the-qaunts-want-here-are-the-top-10?utm_source=markets.businessinsider.com&utm_medium=referral
101.0,8/26/2021 2:09:14 PM,"The Daily Biotech Pulse: Early Approval For Ascendis' Pediatric Growth Hormone Deficiency Treatment, Redhill Biopharma Spikes On Positive COVID-19 Drug Data, RenovoRx IPO",Benzinga,/news/stocks/the-daily-biotech-pulse-early-approval-for-ascendis-pediatric-growth-hormone-deficiency-treatment-redhill-biopharma-spikes-on-positive-covid-19-drug-data-renovorx-ipo-1030760636
102.0,8/27/2021 1:35:25 PM,"The Daily Biotech Pulse: MorphoSys-Incyte Snag European Nod, Immutep Granted Chinese Patent, Bolt Biotherapeutics Strike Oncology Collaboration",Benzinga,/news/stocks/the-daily-biotech-pulse-morphosys-incyte-snag-european-nod-immutep-granted-chinese-patent-bolt-biotherapeutics-strike-oncology-collaboration-1030763431
103.0,8/27/2021 3:47:08 PM,Notable earnings before Monday's open,Seeking Alpha,https://seekingalpha.com/news/3734925-notable-earnings-before-mondays-open?utm_source=markets.businessinsider.com&utm_medium=referral
104.0,8/28/2021 3:01:21 PM,Here's what Wall Street expects from Catalent's earnings report,Markets Insider Automation,/news/stocks/catalent-stock-price-q4-earnings-preview-1030764689
105.0,8/30/2021 5:34:23 AM,Catalent To Acquire Bettera For $1 Bln : Report ,RTTNews,/news/stocks/catalent-to-acquire-bettera-for-1-bln-report-1030765324
106.0,8/30/2021 10:05:48 AM,"Earnings Scheduled For August 30, 2021",Benzinga,/news/stocks/earnings-scheduled-for-august-30-2021-1030766148
107.0,8/30/2021 12:22:55 PM,"A Peek Into The Markets: US Stock Futures Edge Higher After S&P 500, Nasdaq Hit Record Highs",Benzinga,/news/stocks/a-peek-into-the-markets-us-stock-futures-edge-higher-after-s-p-500-nasdaq-hit-record-highs-1030766402
108.0,8/30/2021 1:00:00 PM,Highlander Partners Announces the Signing of a Definitive Agreement to Sell Bettera Brands to Catalent,PR Newswire,/news/stocks/highlander-partners-announces-the-signing-of-a-definitive-agreement-to-sell-bettera-brands-to-catalent-1030766535
109.0,8/30/2021 1:27:34 PM,Catalent Q4 Profit Tops Estimates; Announces Acquisition Of Bettera Holdings ,RTTNews,/news/stocks/catalent-q4-profit-tops-estimates-announces-acquisition-of-bettera-holdings-1030766588
110.0,8/30/2021 4:21:07 PM,Mid-Morning Market Update: Markets Mixed; Catalent To Acquire Bettera,Benzinga,/news/stocks/mid-morning-market-update-markets-mixed-catalent-to-acquire-bettera-1030767229
111.0,8/30/2021 6:29:10 PM,Mid-Day Market Update: Nasdaq Jumps Over 100 Points; Astra Space Shares Plunge,Benzinga,/news/stocks/mid-day-market-update-nasdaq-jumps-over-100-points-astra-space-shares-plunge-1030767547
112.0,8/30/2021 8:35:18 PM,Mid-Afternoon Market Update: Affirm Shares Jump Following News Of Amazon Partnership; Adtran Shares Drop,Benzinga,/news/stocks/mid-afternoon-market-update-affirm-shares-jump-following-news-of-amazon-partnership-adtran-shares-drop-1030767776
113.0,8/31/2021 1:59:24 PM,10 Biggest Price Target Changes For Tuesday,Benzinga,/news/stocks/10-biggest-price-target-changes-for-tuesday-1030769447
114.0,9/2/2021 2:19:58 PM,"The Daily Biotech Pulse: Assembly Bio Halts HBV Study, Moderna Initiates Submission For COVID-19 Booster Dose, FDA Nod For BeiGene, Tiziana Out-Licenses Foralumab",Benzinga,/news/stocks/the-daily-biotech-pulse-assembly-bio-halts-hbv-study-moderna-initiates-submission-for-covid-19-booster-dose-fda-nod-for-beigene-tiziana-out-licenses-foralumab-1030776427
115.0,9/3/2021 1:31:13 PM,"The Daily Biotech Pulse: Cellect Jumps On First Apograft Transplantation, AstraZeneca, European Commission Bury Legal Hatchet, Cassava Defends Itself",Benzinga,/news/stocks/the-daily-biotech-pulse-cellect-jumps-on-first-apograft-transplantation-astrazeneca-european-commission-bury-legal-hatchet-cassava-defends-itself-1030779479
116.0,9/8/2021 1:32:08 PM,"The Daily Biotech Pulse: MacroGenics' Clinical Trial Disappointment, Sanofi to Buy Kadmon, Alector Loses 2 Key Executives, ADMA's FDA Nod",Benzinga,/news/stocks/the-daily-biotech-pulse-macrogenics-clinical-trial-disappointment-sanofi-to-buy-kadmon-alector-loses-2-key-executives-adma-s-fda-nod-1030786678
117.0,9/8/2021 6:37:02 PM,Where Catalent Stands With Analysts,Benzinga,/news/stocks/where-catalent-stands-with-analysts-1030787970
118.0,9/9/2021 2:17:07 PM,"The Daily Biotech Pulse: ProQR-Lilly R&D Partnership, Sanofi's Pemphigus Trial Disappointment, Humanigen's COVID-19 Drug Denied Emergency Use Authorization",Benzinga,/news/stocks/the-daily-biotech-pulse-proqr-lilly-r-d-partnership-sanofi-s-pemphigus-trial-disappointment-humanigen-s-covid-19-drug-denied-emergency-use-authorization-1030789942
119.0,9/10/2021 2:00:05 PM,"The Daily Biotech Pulse: Apellis Sinks On Data, Endo Shines On Opioid Litigation Settlement, T2 Biosystems Soars On Mutant Detection Ability of COVID Test",Benzinga,/news/stocks/the-daily-biotech-pulse-apellis-sinks-on-data-endo-shines-on-opioid-litigation-settlement-t2-biosystems-soars-on-mutant-detection-ability-of-covid-test-1030792468
120.0,9/23/2021 6:46:00 PM,"Catalent Pharma Solutions, Inc. -- Moody's assigns B1 rating to Catalent's notes offering",Moodys,/news/bonds/catalent-pharma-solutions-inc-moody-s-assigns-b1-rating-to-catalent-s-notes-offering-1030819830
121.0,10/6/2021 6:21:09 PM,7 Healthcare Stocks to Add to Your Portfolio,InvestorPlace,/news/stocks/7-healthcare-stocks-to-add-to-your-portfolio-1030848379
122.0,10/31/2021 7:23:54 PM,"The Week Ahead In Biotech (Oct. 31-Nov. 6): Earnings Pick Up Pace, Eton Awaits Seizure Drug Approval, Kidney Conference, More IPOs In The Pipeline",Benzinga,/news/stocks/the-week-ahead-in-biotech-oct-31-nov-6-earnings-pick-up-pace-eton-awaits-seizure-drug-approval-kidney-conference-more-ipos-in-the-pipeline-1030917750
123.0,11/1/2021 3:10:27 PM,Notable earnings before Tuesday's open,Seeking Alpha,https://seekingalpha.com/news/3761481-notable-earnings-before-tuesdays-open?utm_source=markets.businessinsider.com&utm_medium=referral
124.0,11/1/2021 4:24:53 PM,Catalent FQ1 2022 Earnings Preview,Seeking Alpha,https://seekingalpha.com/news/3761534-catalent-fq1-2022-earnings-preview?utm_source=markets.businessinsider.com&utm_medium=referral
125.0,11/2/2021 11:05:31 AM,"Catalent EPS beats by $0.05, revenue in-line",Seeking Alpha,https://seekingalpha.com/news/3762681-catalent-eps-beats-by-005-revenue-in-line?utm_source=markets.businessinsider.com&utm_medium=referral
126.0,11/2/2021 12:52:53 PM,"The Daily Biotech Pulse: Pfizer Reports Solid Q3 Earnings, Regulatory Setback For Legend, Lilly to Supply Additional COVID-19 Antibody Cocktails To US",Benzinga,/news/stocks/the-daily-biotech-pulse-pfizer-reports-solid-q3-earnings-regulatory-setback-for-legend-lilly-to-supply-additional-covid-19-antibody-cocktails-to-us-1030925781
127.0,11/3/2021 5:40:08 PM,Expert Ratings For Catalent,Benzinga,/news/stocks/expert-ratings-for-catalent-1030933497
128.0,12/16/2021 4:13:40 PM,"Benzinga's Top Ratings Upgrades, Downgrades For December 16, 2021",Benzinga,/news/stocks/benzinga-s-top-ratings-upgrades-downgrades-for-december-16-2021-1031050813
129.0,12/17/2021 4:38:42 PM,Catalent manufactured peptic ulcer therapy granted FDA approval,Seeking Alpha,https://seekingalpha.com/news/3781364-catalent-manufactured-peptic-ulcer-therapy-granted-fda-approval?utm_source=markets.businessinsider.com&utm_medium=referral
130.0,12/20/2021 8:44:27 PM,Catalent at a four-month low amid speculation linking it to Novo’s supply issues,Seeking Alpha,https://seekingalpha.com/news/3782046-catalent-at-a-four-month-low-amid-speculation-linking-it-to-novos-supply-issues?utm_source=markets.businessinsider.com&utm_medium=referral
131.0,1/5/2022 1:23:01 PM,Catalent announces CEO transition plans,Seeking Alpha,https://seekingalpha.com/news/3785356-catalent-announces-ceo-transition-plans?utm_source=markets.businessinsider.com&utm_medium=referral
132.0,1/27/2022 5:02:48 PM,Expert Ratings For Catalent,Benzinga,/news/stocks/expert-ratings-for-catalent-1031136349
133.0,1/31/2022 2:20:54 PM,"The Week Ahead In Biotech (Jan 31-Feb 5): Merck, Bristol-Myers Squibb, Lilly & Novartis Headline Large-Cap Biopharma Earnings News",Benzinga,/news/stocks/the-week-ahead-in-biotech-jan-31-feb-5-merck-bristol-myers-squibb-lilly-novartis-headline-large-cap-biopharma-earnings-news-1031144306
134.0,1/31/2022 3:01:13 PM,Here's what Wall Street expects from Catalent's earnings,Markets Insider Automation,/news/stocks/catalent-stock-quarter-earnings-preview-q2-1031144454
135.0,1/31/2022 3:16:32 PM,Notable earnings before Tuesday's open,Seeking Alpha,https://seekingalpha.com/news/3793548-notable-earnings-before-tuesdays-open?utm_source=markets.businessinsider.com&utm_medium=referral
136.0,1/31/2022 5:36:59 PM,Catalent FQ2 2022 Earnings Preview,Seeking Alpha,https://seekingalpha.com/news/3793639-catalent-q2-2022-earnings-preview?utm_source=markets.businessinsider.com&utm_medium=referral
137.0,2/1/2022 12:06:35 PM,"Catalent Non-GAAP EPS of $0.90 beats by $0.07, revenue of $1.22B beats by $70M",Seeking Alpha,https://seekingalpha.com/news/3793933-catalent-non-gaap-eps-of-0_90-beats-0_07-revenue-of-1_22b-beats-70m?utm_source=markets.businessinsider.com&utm_medium=referral
138.0,2/1/2022 2:28:49 PM,"The Daily Biotech Pulse: ImmunityBio Reports Positive Readout, Valneva Starts Late-Stage Chikungunya Vaccine Study, Sio Gene Shelves Parkinson's Program",Benzinga,/news/stocks/the-daily-biotech-pulse-immunitybio-reports-positive-readout-valneva-starts-late-stage-chikungunya-vaccine-study-sio-gene-shelves-parkinson-s-program-1031149041
139.0,2/1/2022 3:59:13 PM,"Catalent Rises As Quarterly Results, Outlook Better Than Consensus ",RTTNews,/news/stocks/catalent-rises-as-quarterly-results-outlook-better-than-consensus-1031149695
140.0,3/17/2022 1:15:27 PM,TFF Pharma in pact with U.S. army for needle-free medical countermeasures,Seeking Alpha,https://seekingalpha.com/news/3814589-tff-pharma-in-pact-with-us-army-for-needle-free-medical-countermeasures?utm_source=markets.businessinsider.com&utm_medium=referral
141.0,3/22/2022 1:31:50 PM,"The Daily Biotech Pulse: Merck's Keytruda Snags Another FDA Approval, Pfizer Strikes COVID-19 Pill Supply Deal, Argenx Reports Positive Late-Stage Readout",Benzinga,/news/stocks/the-daily-biotech-pulse-merck-s-keytruda-snags-another-fda-approval-pfizer-strikes-covid-19-pill-supply-deal-argenx-reports-positive-late-stage-readout-1031298122
142.0,4/15/2022 12:00:10 PM,Catalent adds 4 manufacturing suites at Missouri facility,Seeking Alpha,https://seekingalpha.com/news/3823641-catalent-adds-4-manufacturing-suites-at-missouri-facility?utm_source=markets.businessinsider.com&utm_medium=referral
143.0,4/20/2022 5:03:06 PM,Bank of America is cautious on life sciences companies ahead of earnings,Seeking Alpha,https://seekingalpha.com/news/3824851-bank-of-america-is-cautious-on-life-sciences-companies-ahead-of-earnings?utm_source=markets.businessinsider.com&utm_medium=referral
144.0,5/2/2022 2:26:02 PM,Notable earnings before Tuesday's open,Seeking Alpha,https://seekingalpha.com/news/3830038-notable-earnings-before-tuesdays-open?utm_source=markets.businessinsider.com&utm_medium=referral
145.0,5/2/2022 3:01:13 PM,Here's what Wall Street expects from Catalent's earnings,Markets Insider Automation,/news/stocks/catalent-quarter-earnings-preview-q3-1031408787
146.0,5/2/2022 3:23:04 PM,Catalent FQ3 2022 Earnings Preview,Seeking Alpha,https://seekingalpha.com/news/3830132-catalent-q3-2022-earnings-preview?utm_source=markets.businessinsider.com&utm_medium=referral
147.0,5/3/2022 11:14:29 AM,"Catalent Non-GAAP EPS of $1.04 beats by $0.10, revenue of $1.27B beats by $50M",Seeking Alpha,https://seekingalpha.com/news/3830833-catalent-non-gaap-eps-of-1_04-beats-0_10-revenue-of-1_27b-beats-50m?utm_source=markets.businessinsider.com&utm_medium=referral
148.0,5/3/2022 2:04:04 PM,"Sonoma, XORTX top healthcare gainers; Spero, Semler Scientific lead losers' pack",Seeking Alpha,https://seekingalpha.com/news/3831017-sonoma-xortx-top-healthcare-gainers-spero-semler-scientific-lead-losers-pack?utm_source=markets.businessinsider.com&utm_medium=referral
149.0,5/3/2022 3:09:32 PM,Catalent jumps as guidance raise highlights post-COVID growth,Seeking Alpha,https://seekingalpha.com/news/3831065-ctlt-stock-jumps-as-guidance-raise-highlights-post-covid-growth?utm_source=markets.businessinsider.com&utm_medium=referral
150.0,5/3/2022 6:14:47 PM,41 Stocks Moving In Tuesday's Mid-Day Session,Benzinga,/news/stocks/41-stocks-moving-in-tuesday-s-mid-day-session-1031414933
151.0,5/4/2022 11:04:58 AM,80 Biggest Movers From Yesterday,Benzinga,/news/stocks/80-biggest-movers-from-yesterday-1031418654
152.0,5/4/2022 6:14:36 PM,Morgan Stanley Maintains Overweight Rating for Catalent: Here's What You Need To Know,Benzinga,/news/stocks/morgan-stanley-maintains-overweight-rating-for-catalent-here-s-what-you-need-to-know-1031421090
153.0,5/20/2022 8:48:43 AM,Catalent to spend $175M to expand Kentucky manufacturing site,Seeking Alpha,https://seekingalpha.com/news/3841246-catalent-to-spend-175m-to-expand-kentucky-manufacturing-site?utm_source=markets.businessinsider.com&utm_medium=referral
154.0,5/26/2022 9:31:16 PM,Quant Ratings Updated on 75 Stocks,InvestorPlace,/news/stocks/quant-ratings-updated-on-75-stocks-1031494096
155.0,7/5/2022 1:16:18 PM,Catalent restructures operating segments; chief commercial officer resigns,Seeking Alpha,https://seekingalpha.com/news/3854154-catalent-restructures-operating-segments-chief-commercial-officer-resigns?utm_source=businessinsider&utm_medium=referral
156.0,8/10/2022 5:28:22 AM,Catalent To Acquire Metrics Contract Services From Mayne Pharma For $475 Mln ,RTTNews,/news/stocks/catalent-to-acquire-metrics-contract-services-from-mayne-pharma-for-475-mln-1031667625
157.0,8/10/2022 8:03:07 AM,Catalent to acquire Metrics Contract Services for $475M,Seeking Alpha,https://seekingalpha.com/news/3870445-catalent-to-acquire-metrics-contract-services-for-475m?utm_source=businessinsider&utm_medium=referral
158.0,8/11/2022 8:42:18 PM,Repligen gains after report of rejected takeover offer (update),Seeking Alpha,https://seekingalpha.com/news/3871770-repligen-briefly-turns-positive-after-report-of-rejected-takeover-offer?utm_source=businessinsider&utm_medium=referral
159.0,8/13/2022 12:30:40 AM,"Catalent-Repligen Merger 'Seems Unlikely,' This Analyst Says",Benzinga,/news/stocks/catalent-repligen-merger-seems-unlikely-this-analyst-says-1031680869
160.0,8/24/2022 8:18:52 PM,Erytech drops plans to pursue FDA approval for leukemia therapy,Seeking Alpha,https://seekingalpha.com/news/3876365-eryp-stock-on-watch-amid-plans-to-halt-development-of-leukemia-therapy?utm_source=businessinsider&utm_medium=referral
161.0,8/26/2022 2:24:24 PM,Notable earnings before Monday's open,Seeking Alpha,https://seekingalpha.com/news/3877090-notable-earnings-before-mondays-open?utm_source=businessinsider&utm_medium=referral
162.0,8/27/2022 8:00:00 PM,"Biologic medicines, COVID vaccines spurring growth for contract injectable packaging firms",Seeking Alpha,https://seekingalpha.com/news/3877138-biologic-medicines-covid-vaccines-spurring-growth-for-contract-injectable-packaging-firms?utm_source=businessinsider&utm_medium=referral
163.0,8/28/2022 3:01:13 PM,Here's what Wall Street expects from Catalent's earnings,Markets Insider Automation,/news/stocks/catalent-stock-q4-earnings-preview-1031709360
164.0,8/29/2022 11:03:26 AM,"Catalent Non-GAAP EPS of $1.19 beats by $0.04, revenue of $1.31B misses by $20M",Seeking Alpha,https://seekingalpha.com/news/3877341-catalent-non-gaap-eps-of-1_19-beats-0_04-revenue-of-1_31b-misses-20m?utm_source=businessinsider&utm_medium=referral
165.0,8/29/2022 11:54:24 AM,Catalent drops ~10% after fiscal Q4 results as outlook disappoints,Seeking Alpha,https://seekingalpha.com/news/3877364-ctlt-stock-drops-as-fiscal-2022-outlook-disappoints?utm_source=businessinsider&utm_medium=referral
166.0,8/29/2022 2:45:00 PM,Catalent Inc hosts conference call for investors,Markets Insider Automation,/news/stocks/catalent_conference-1030731270
167.0,8/29/2022 6:49:59 PM,"Why Chimerix Is Trading Higher By Over 19%, Here Are 53 Stocks Moving In Monday's Mid-Day Session",Benzinga,/news/stocks/why-chimerix-is-trading-higher-by-over-19-here-are-53-stocks-moving-in-monday-s-mid-day-session-1031711539
168.0,8/30/2022 10:12:02 AM,"Catalent, Tellurian And Other Big Losers From Monday",Benzinga,/news/stocks/catalent-tellurian-and-other-big-losers-from-monday-1031712612
169.0,8/30/2022 11:23:25 AM,Why Bed Bath & Beyond Jumped Around 25%; Here Are 68 Biggest Movers From Yesterday,Benzinga,/news/stocks/why-bed-bath-beyond-jumped-around-25-here-are-68-biggest-movers-from-yesterday-1031712731
170.0,8/30/2022 1:21:37 PM,Catalent To $115? Here Are 5 Other Price Target Changes For Tuesday,Benzinga,/news/stocks/catalent-to-115-here-are-5-other-price-target-changes-for-tuesday-1031713042
171.0,8/30/2022 1:40:55 PM,"HC Wainwright Boosts Price Target On This Stock By 167%, Plus B of A Securities Predicts $40 For This Online Travel Stock",Benzinga,/news/stocks/hc-wainwright-boosts-price-target-on-this-stock-by-167-plus-b-of-a-securities-predicts-40-for-this-online-travel-stock-1031713101
172.0,8/30/2022 2:36:29 PM,Catalent Faces Several Price Target Cuts By Analysts After Q4 Results,Benzinga,/news/stocks/catalent-faces-several-price-target-cuts-by-analysts-after-q4-results-1031713353
173.0,8/30/2022 4:14:48 PM,Where Catalent Stands With Analysts,Benzinga,/news/stocks/where-catalent-stands-with-analysts-1031713888
174.0,8/30/2022 7:01:35 PM,Expert Ratings for Catalent,Benzinga,/news/stocks/expert-ratings-for-catalent-1031714288
175.0,8/30/2022 9:00:26 PM,"Despite Price Cut, RBC Capital Is Bullish On Catalent's Long Term Targets",Benzinga,/news/stocks/despite-price-cut-rbc-capital-is-bullish-on-catalent-s-long-term-targets-1031714441
176.0,9/21/2022 11:14:08 AM,Pfizer/BioNTech lead new booster shot rollout amid supply issues for Moderna,Seeking Alpha,https://seekingalpha.com/news/3884728-pfizerbiontech-lead-new-booster-shot-rollout-amid-supply-issues-for-moderna?utm_source=businessinsider&utm_medium=referral
177.0,10/2/2022 4:00:31 PM,COVID stocks lag U.S. biopharma in Q3; Alzheimer’s theme regains focus,Seeking Alpha,https://seekingalpha.com/news/3887740-covid-stocks-lag-us-biopharma-in-q3-alzheimers-theme-regains-focus?utm_source=businessinsider&utm_medium=referral
178.0,10/6/2022 9:27:36 PM,7 Analysts Have This to Say About Catalent,Benzinga,/news/stocks/7-analysts-have-this-to-say-about-catalent-1031788548
179.0,10/31/2022 3:01:13 PM,Here's what Wall Street expects from Catalent's earnings,Markets Insider Automation,/news/stocks/catalent-q1-earnings-preview-1031853763
180.0,10/31/2022 3:21:29 PM,Notable earnings before Tuesday's open,Seeking Alpha,https://seekingalpha.com/news/3897806-notable-earnings-before-tuesdays-open?utm_source=businessinsider&utm_medium=referral
181.0,10/31/2022 5:49:40 PM,Catalent Q1 2023 Earnings Preview,Seeking Alpha,https://seekingalpha.com/news/3897951-catalent-q1-2023-earnings-preview?utm_source=businessinsider&utm_medium=referral
182.0,11/1/2022 11:01:49 AM,"Catalent Non-GAAP EPS of $0.71 beats by $0.15, revenue of $1.02B misses by $60M, cuts FY22 revenue outlook",Seeking Alpha,https://seekingalpha.com/news/3898372-catalent-non-gaap-eps-of-071-beats-by-015-revenue-of-102b-misses-by-60m-cuts-fy22-revenue-outlook?utm_source=businessinsider&utm_medium=referral
183.0,11/1/2022 1:35:21 PM,"Catalent breaches 52-week low, falls 25% on dismal Q3 earnings",Seeking Alpha,https://seekingalpha.com/news/3898546-catalent-breaches-52-week-low-falls-25-on-dismal-q3-earnings?utm_source=businessinsider&utm_medium=referral
184.0,11/1/2022 2:00:28 PM,"Abiomed, Aeglea lead healthcare gainers; Catalent, Acorda among losers",Seeking Alpha,https://seekingalpha.com/news/3898562-abiomed-aeglea-lead-healthcare-gainers-catalent-acorda-among-losers?utm_source=businessinsider&utm_medium=referral
185.0,11/1/2022 3:21:28 PM,US Stocks Trade Lower Ahead Of Fed Meeting; Pfizer Earnings Top Views,Benzinga,/news/stocks/us-stocks-trade-lower-ahead-of-fed-meeting-pfizer-earnings-top-views-1031859177
186.0,11/1/2022 4:30:06 PM,Why Is Catalent (CTLT) Stock Down 24% Today?,InvestorPlace,/news/stocks/why-is-catalent-ctlt-stock-down-24-today-1031859596
187.0,11/1/2022 4:36:23 PM,"Goodyear Tire, Catalent, Zebra Technologies And Some Other Big Stocks Moving Lower On Tuesday",Benzinga,/news/stocks/goodyear-tire-catalent-zebra-technologies-and-some-other-big-stocks-moving-lower-on-tuesday-1031859431
188.0,11/1/2022 4:45:12 PM,Unity Biotechnology (UBX) Stock Pops on Positive Study Data,InvestorPlace,/news/stocks/unity-biotechnology-ubx-stock-pops-on-positive-study-data-1031859634
189.0,11/1/2022 5:01:23 PM,Dow Drops Over 200 Points; Crude Oil Rises Sharply,Benzinga,/news/stocks/dow-drops-over-200-points-crude-oil-rises-sharply-1031859491
190.0,11/1/2022 5:38:19 PM,Why Abiomed Shares Are Trading Higher By Over 50%? Here Are 60 Stocks Moving In Tuesday's Mid-Day Session,Benzinga,/news/stocks/why-abiomed-shares-are-trading-higher-by-over-50-here-are-60-stocks-moving-in-tuesday-s-mid-day-session-1031859608
191.0,11/1/2022 5:40:03 PM,MNSO and CLEU among mid-day movers,Seeking Alpha,https://seekingalpha.com/news/3898816-mnso-and-cleu-among-mid-day-movers?utm_source=businessinsider&utm_medium=referral
192.0,11/1/2022 7:57:55 PM,Nasdaq Down 60 Points; Eli Lilly Lowers Earnings Forecast,Benzinga,/news/stocks/nasdaq-down-60-points-eli-lilly-lowers-earnings-forecast-1031859928
193.0,11/2/2022 10:07:53 AM,Why Harsco Shares Surged Over 22%; Here Are 80 Biggest Movers From Yesterday,Benzinga,/news/stocks/why-harsco-shares-surged-over-22-here-are-80-biggest-movers-from-yesterday-1031862982
194.0,11/2/2022 12:36:17 PM,KeyBanc Sticks to Their Buy Rating for Catalent (CTLT),TipRanks,/news/stocks/keybanc-sticks-to-their-buy-rating-for-catalent-ctlt-1031864021
195.0,11/2/2022 2:28:07 PM,Analyst Ratings for Catalent,Benzinga,/news/stocks/analyst-ratings-for-catalent-1031864249
196.0,11/2/2022 3:06:35 PM,"Benzinga's Top Ratings Upgrades, Downgrades For November 2, 2022",Benzinga,/news/stocks/benzinga-s-top-ratings-upgrades-downgrades-for-november-2-2022-1031864883
197.0,11/2/2022 4:43:51 PM,Catalent downgraded to neutral at BofA due to lack of near-term visibility,Seeking Alpha,https://seekingalpha.com/news/3899895-catalent-downgraded-to-neutral-at-bofa-due-to-lack-of-near-term-visibility?utm_source=businessinsider&utm_medium=referral
198.0,11/2/2022 9:18:05 PM,Where Catalent Stands With Analysts,Benzinga,/news/stocks/where-catalent-stands-with-analysts-1031866208
199.0,11/7/2022 3:25:14 PM,"Benzinga's Top Ratings Upgrades, Downgrades For November 7, 2022",Benzinga,/news/stocks/benzinga-s-top-ratings-upgrades-downgrades-for-november-7-2022-1031881903
200.0,11/19/2022 1:50:57 AM,"Analysts Offer Insights on Healthcare Companies: Catalent (CTLT), Xenon (XENE) and Alcon (ALC)",TipRanks,/news/stocks/analysts-offer-insights-on-healthcare-companies-catalent-ctlt-xenon-xene-and-alcon-alc-1031926532
201.0,12/6/2022 2:44:39 PM,Eli Lilly sees “unprecedented” demand for its diabetes drugs,Seeking Alpha,https://seekingalpha.com/news/3914335-lly-stock-company-sees-unprecedented-demand-for-diabetes-drugs?utm_source=businessinsider&utm_medium=referral
202.0,12/7/2022 2:55:29 PM,Catalent (CTLT) Receives a Rating Update from a Top Analyst,TipRanks,/news/stocks/catalent-ctlt-receives-a-rating-update-from-a-top-analyst-1031958308
203.0,12/8/2022 5:08:03 PM,Catalent falls after new short call from Glasshouse Research,Seeking Alpha,https://seekingalpha.com/news/3915412-catalent-falls-after-new-short-call-from-glasshouse-research?utm_source=businessinsider&utm_medium=referral
204.0,12/16/2022 5:36:44 PM,Eli Lilly diabetes drugs in shortage due to rising demand,Seeking Alpha,https://seekingalpha.com/news/3918115-eli-lilly-diabetes-drugs-in-shortage-due-to-rising-demand?utm_source=businessinsider&utm_medium=referral
205.0,12/19/2022 2:28:12 PM,Catalent Selects Martin Carroll As Chair ,RTTNews,/news/stocks/catalent-selects-martin-carroll-as-chair-1031979994
206.0,12/19/2022 4:00:50 PM,"Benzinga's Top Ratings Upgrades, Downgrades For December 19, 2022",Benzinga,/news/stocks/benzinga-s-top-ratings-upgrades-downgrades-for-december-19-2022-1031980293
207.0,12/22/2022 10:50:18 PM,Humanigen to pay Catalent Pharma $12M to settle supply agreement dispute,Seeking Alpha,https://seekingalpha.com/news/3920127-humanigen-to-pay-catalent-pharma-12m-to-settle-supply-agreement-dispute?utm_source=businessinsider&utm_medium=referral
208.0,12/27/2022 2:50:31 PM,The 10 biggest losers in the S&P 500 this year have seen $1.6 trillion in market value erased,Business Insider,/news/stocks/worst-performing-stocks-meta-tesla-tech-inflation-economy-sp500-2022-12
209.0,1/5/2023 1:54:55 PM,Catalent to make Sarepta Therapeutics' muscle wasting gene therapy under supply deal,Seeking Alpha,https://seekingalpha.com/news/3922328-catalent-to-make-sarepta-therapeutics-muscle-wasting-gene-therapy-under-supply-deal?utm_source=businessinsider&utm_medium=referral
210.0,1/5/2023 10:14:01 PM,Acorda strikes new global supply deal with Catalent for its inhalation powder Inbrija,Seeking Alpha,https://seekingalpha.com/news/3922543-acorda-strikes-new-global-supply-deal-with-catalent-for-its-inhalation-powder-inbrija?utm_source=businessinsider&utm_medium=referral
211.0,1/9/2023 1:30:00 PM,Avantor® and Catalent Enter into Multi-Year Supply and Services Agreement,PR Newswire,/news/stocks/avantor-and-catalent-enter-into-multi-year-supply-and-services-agreement-1032006806
212.0,1/13/2023 4:16:22 PM,Johnson & Johnson is scaling back COVID-19 vaccine production – WSJ,Seeking Alpha,https://seekingalpha.com/news/3924553-jnj-stock-falls-as-company-scaling-back-covid-19-vaccine-production?utm_source=businessinsider&utm_medium=referral
213.0,1/13/2023 7:22:37 PM,"Johnson & Johnson Cuts Production, Ends Contracts For Not So Successful COVID-19 Shot",Benzinga,/news/stocks/johnson-johnson-cuts-production-ends-contracts-for-not-so-successful-covid-19-shot-1032018165
214.0,1/24/2023 6:00:24 PM,Barclays Maintains Overweight Rating for Catalent: Here's What You Need To Know,Benzinga,/news/stocks/barclays-maintains-overweight-rating-for-catalent-here-s-what-you-need-to-know-1032037601
215.0,1/24/2023 9:00:38 PM,Analyst Ratings for Catalent,Benzinga,/news/stocks/analyst-ratings-for-catalent-1032037952
216.0,1/30/2023 5:11:19 AM,Analysts Offer Insights on Healthcare Companies: Merck & Company (MRK) and Catalent (CTLT),TipRanks,/news/stocks/analysts-offer-insights-on-healthcare-companies-merck-company-mrk-and-catalent-ctlt-1032048996
217.0,2/5/2023 12:13:24 AM,Danaher said to be interested in acquiring contract manufacturer Catalent,Seeking Alpha,https://seekingalpha.com/news/3932097-danaher-shows-takeover-interest-contract-manufacturer-catalent?utm_source=businessinsider&utm_medium=referral
218.0,2/6/2023 12:33:26 PM,Why PayPal And Coinbase Are Trading Lower; Here Are 20 Stocks Moving Premarket,Benzinga,/news/stocks/why-paypal-and-coinbase-are-trading-lower-here-are-20-stocks-moving-premarket-1032069945
219.0,2/6/2023 12:37:23 PM,Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday,InvestorPlace,/news/stocks/todays-biggest-pre-market-stock-movers-10-top-gainers-and-losers-on-monday-feb-6-1032070127
220.0,2/6/2023 12:45:04 PM,Nasdaq Futures Indicate Subdued Start For Wall Street: Jerome Powell's Speech On Tuesday Key Highlight This Week,Benzinga,/news/stocks/nasdaq-futures-indicate-subdued-start-for-wall-street-jerome-powell-s-speech-on-tuesday-key-highlight-this-week-1032069972
221.0,2/6/2023 1:31:58 PM,"SPCE, AI and EXPR are among pre market gainers",Seeking Alpha,https://seekingalpha.com/news/3932270-spce-ai-and-expr-are-among-pre-market-gainers?utm_source=businessinsider&utm_medium=referral
222.0,2/6/2023 3:01:13 PM,Catalent earnings: here's what Wall Street expects,Markets Insider Automation,/news/stocks/catalent-quarter-earnings-preview-q2-1032070363
223.0,2/6/2023 3:09:32 PM,Notable earnings before Tuesday's open,Seeking Alpha,https://seekingalpha.com/news/3932331-notable-earnings-before-tuesdays-open?utm_source=businessinsider&utm_medium=referral
224.0,2/6/2023 3:18:05 PM,Catalent climbs 22% on Danaher interest as Jefferies sees $93/share deal,Seeking Alpha,https://seekingalpha.com/news/3932337-ctlt-stock-climbs-danaher-interest-jefferies-sees-93-share-deal?utm_source=businessinsider&utm_medium=referral
225.0,2/6/2023 3:48:48 PM,Why Is Catalent (NYSE:CTLT) Stock Up 20% Today?,InvestorPlace,/news/stocks/why-is-catalent-nysectlt-stock-up-20-today-1032070835
226.0,2/6/2023 3:54:48 PM,BBIG Stock Alert: VVIP Ventures Acquires Major Outlets From a360 Media,InvestorPlace,/news/stocks/bbig-stock-alert-vvip-ventures-acquires-major-outlets-from-a360-media-1032070833
227.0,2/6/2023 4:24:48 PM,NEM Stock Alert: What to Know as Newmont Offers to Buy Newcrest Mining,InvestorPlace,/news/stocks/nem-stock-alert-what-to-know-as-newmont-offers-to-buy-newcrest-mining-1032070866
228.0,2/6/2023 8:31:45 PM,"Nasdaq, S&P, Dow set to end lower as market continues to grapple with hot jobs report",Seeking Alpha,https://seekingalpha.com/news/3932372-sp500-nasdaq-dow-jones-stock-market-jobs-report-earnings?utm_source=businessinsider&utm_medium=referral
229.0,2/6/2023 9:01:35 PM,Nasdaq Down Over 100 Points; Tyson Foods Posts Downbeat Earnings,Benzinga,/news/stocks/nasdaq-down-over-100-points-tyson-foods-posts-downbeat-earnings-1032071309
230.0,2/6/2023 11:20:37 PM,Why did Catalent stock soar today? Potential takeover by Danaher,Seeking Alpha,https://seekingalpha.com/news/3932651-why-did-catalent-stock-soar-today-potential-takeover-by-danaher?utm_source=businessinsider&utm_medium=referral
231.0,2/7/2023 12:05:00 PM,Catalent reports mixed Q2 earnings; reaffirms FY23 guidance,Seeking Alpha,https://seekingalpha.com/news/3932741-catalent-reports-mixed-q2-earnings-reaffirms-fy23-guidance?utm_source=businessinsider&utm_medium=referral
232.0,2/7/2023 1:36:11 PM,Catalent gains amid buyout chatter as Moderna extends COVID partnership,Seeking Alpha,https://seekingalpha.com/news/3932816-ctlt-stock-gains-moderna-extends-covid-partnership?utm_source=businessinsider&utm_medium=referral
233.0,2/8/2023 4:30:26 AM,Wall Street Analysts Are Bullish on Top Healthcare Picks,TipRanks,/news/stocks/wall-street-analysts-are-bullish-on-top-healthcare-picks-1032075925
234.0,2/8/2023 1:15:04 PM,Catalent (CTLT) Gets a Buy from Jefferies,TipRanks,/news/stocks/catalent-ctlt-gets-a-buy-from-jefferies-1032078484
235.0,2/8/2023 4:26:16 PM,Bank of America Securities Sticks to Their Hold Rating for Catalent (CTLT),TipRanks,/news/stocks/bank-of-america-securities-sticks-to-their-hold-rating-for-catalent-ctlt-1032079381
236.0,2/9/2023 4:31:13 PM,"Analysts’ Opinions Are Mixed on These Healthcare Stocks: Molina Healthcare (MOH), Steris (STE) and Catalent (CTLT)",TipRanks,/news/stocks/analysts-opinions-are-mixed-on-these-healthcare-stocks-molina-healthcare-moh-steris-ste-and-catalent-ctlt-1032083721
237.0,2/10/2023 4:14:15 PM,"Tesla, NVIDIA make the list of Wall Street’s top performing large-cap names so far in 2023",Seeking Alpha,https://seekingalpha.com/news/3934837-wall-streets-top-performing-large-cap-names-each-return-more-than-50-in-2023?utm_source=businessinsider&utm_medium=referral
238.0,2/14/2023 8:21:33 PM,"Maverick Capital exits Intel, Carvana in Q4; adds Catalent, CBRE",Seeking Alpha,https://seekingalpha.com/news/3935947-maverick-capital-exits-intel-carvana-in-q4-adds-catalent-cbre?utm_source=businessinsider&utm_medium=referral
239.0,2/16/2023 1:45:37 AM,RBC Capital Sticks to Its Buy Rating for Catalent (CTLT),TipRanks,/news/stocks/rbc-capital-sticks-to-its-buy-rating-for-catalent-ctlt-1032100653
240.0,3/1/2023 2:00:00 AM,"CTLT EQUITY ALERT: ROSEN, A GLOBALLY RESPECTED LAW FIRM, Encourages Catalent, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - CTLT",PR Newswire,/news/stocks/ctlt-equity-alert-rosen-a-globally-respected-law-firm-encourages-catalent-inc-investors-to-secure-counsel-before-important-deadline-in-securities-class-action-ctlt-1032133624
241.0,3/2/2023 12:19:19 AM,"Tesla among top S&P 500 gainers in February, Moderna one of the biggest losers",Seeking Alpha,https://seekingalpha.com/news/3943002-tesla-among-top-sp-500-gainers-in-february-moderna-one-of-the-biggest-losers?utm_source=businessinsider&utm_medium=referral
242.0,3/10/2023 12:45:00 AM,"ROSEN, A HIGHLY RECOGNIZED LAW FIRM, Encourages Catalent, Inc. Investors with Losses to Secure Counsel Before Important Deadline in Securities Class Action - CTLT",PR Newswire,/news/stocks/rosen-a-highly-recognized-law-firm-encourages-catalent-inc-investors-with-losses-to-secure-counsel-before-important-deadline-in-securities-class-action-ctlt-1032158290
243.0,3/15/2023 7:45:00 PM,"ROSEN, LEADING TRIAL ATTORNEYS, Encourages Catalent, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - CTLT",PR Newswire,/news/stocks/rosen-leading-trial-attorneys-encourages-catalent-inc-investors-to-secure-counsel-before-important-deadline-in-securities-class-action-ctlt-1032170569
244.0,3/21/2023 11:30:00 PM,"ROSEN, A LONGSTANDING AND TRUSTED FIRM, Encourages Catalent, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - CTLT",PR Newswire,/news/stocks/rosen-a-longstanding-and-trusted-firm-encourages-catalent-inc-investors-to-secure-counsel-before-important-deadline-in-securities-class-action-ctlt-1032183351
245.0,3/24/2023 10:32:42 AM,"5 Best Healthcare Stocks to Invest in Now, According to Analysts",TipRanks,/news/stocks/5-best-healthcare-stocks-to-invest-in-now-according-to-analysts-1032190451
246.0,3/29/2023 1:35:00 AM,"ROSEN, SKILLED INVESTOR COUNSEL, Encourages Catalent, Inc. Investors with Losses to Secure Counsel Before Important Deadline in Securities Class Action - CTLT",PR Newswire,/news/stocks/rosen-skilled-investor-counsel-encourages-catalent-inc-investors-with-losses-to-secure-counsel-before-important-deadline-in-securities-class-action-ctlt-1032198596
247.0,4/3/2023 5:00:39 PM,"Benzinga's Top Ratings Upgrades, Downgrades For April 3, 2023",Benzinga,/news/stocks/benzinga-s-top-ratings-upgrades-downgrades-for-april-3-2023-1032211266
248.0,4/3/2023 9:00:37 PM,Where Catalent Stands With Analysts,Benzinga,/news/stocks/where-catalent-stands-with-analysts-1032211835
249.0,4/4/2023 3:57:51 PM,Catalent downgraded at Barclays citing unclear outlook,Seeking Alpha,https://seekingalpha.com/news/3954386-catalent-stock-downgraded-barclays-unclear-outlook?utm_source=businessinsider&utm_medium=referral
250.0,4/4/2023 5:00:41 PM,"Benzinga's Top Ratings Upgrades, Downgrades For April 4, 2023",Benzinga,/news/stocks/benzinga-s-top-ratings-upgrades-downgrades-for-april-4-2023-1032214238
251.0,4/5/2023 12:00:00 AM,"ROSEN, NATIONALLY REGARDED INVESTOR COUNSEL, Encourages Catalent, Inc. Investors with Losses to Secure Counsel Before Important Deadline in Securities Class Action - CTLT",PR Newswire,/news/stocks/rosen-nationally-regarded-investor-counsel-encourages-catalent-inc-investors-with-losses-to-secure-counsel-before-important-deadline-in-securities-class-action-ctlt-1032215060
252.0,4/10/2023 2:32:14 PM,Valero Energy To Rally 32%? Here Are 10 Other Analyst Forecasts For Monday,Benzinga,/news/stocks/valero-energy-to-rally-32-here-are-10-other-analyst-forecasts-for-monday-1032221976
253.0,4/10/2023 5:00:37 PM,"Benzinga's Top Ratings Upgrades, Downgrades For April 10, 2023",Benzinga,/news/stocks/benzinga-s-top-ratings-upgrades-downgrades-for-april-10-2023-1032222296
254.0,4/10/2023 7:36:01 PM,Catalent upgraded at Deutsche Bank on potential upside to forecasts,Seeking Alpha,https://seekingalpha.com/news/3955405-catalent-stock-upgraded-deutsche-bank-upside?utm_source=businessinsider&utm_medium=referral
255.0,4/13/2023 11:54:33 AM,Sarepta sheds 11% as report hints at early FDA opposition to gene therapy,Seeking Alpha,https://seekingalpha.com/news/3956229-sarepta-stock-falls-report-muscular-dystrophy-therapy?utm_source=businessinsider&utm_medium=referral
256.0,4/13/2023 12:28:20 PM,"CYTO, GFAI and SCLX among pre-market losers",Seeking Alpha,https://seekingalpha.com/news/3956253-cyto-gfai-and-sclx-among-pre-market-losers?utm_source=businessinsider&utm_medium=referral
257.0,4/14/2023 12:20:48 PM,"ARVL, SPR and ATNF among pre-market losers",Seeking Alpha,https://seekingalpha.com/news/3956556-arvl-spr-and-atnf-among-pre-market-losers?utm_source=businessinsider&utm_medium=referral
258.0,4/14/2023 1:40:05 PM,"Catalent plunges 27% on cost, productivity concerns, interim CFO appointed (update)",Seeking Alpha,https://seekingalpha.com/news/3956543-catalent-gets-an-interim-cfo?utm_source=businessinsider&utm_medium=referral
259.0,4/14/2023 5:00:16 PM,"UXIN, TAST and ENVB among mid-day movers",Seeking Alpha,https://seekingalpha.com/news/3956663-uxin-tast-and-envb-among-mid-day-movers?utm_source=businessinsider&utm_medium=referral
260.0,4/14/2023 6:17:34 PM,"Catalent's Operational Inefficiencies: Analyst Downgrades Stock, Seeks Additional Clarity",Benzinga,/news/stocks/catalent-s-operational-inefficiencies-analyst-downgrades-stock-seeks-additional-clarity-1032233383
261.0,4/14/2023 7:02:37 PM,Why Teva Pharmaceutical Shares Are Trading Lower By 11%? Here Are Other Stocks Moving In Friday's Mid-Day Session,Benzinga,/news/stocks/why-teva-pharmaceutical-shares-are-trading-lower-by-11-here-are-other-stocks-moving-in-friday-s-mid-day-session-1032233456
262.0,4/14/2023 10:19:00 PM,"ROSEN, A TOP RANKED FIRM, Encourages Catalent, Inc. Investors to Secure Counsel Before Important April 25 Deadline in Securities Class Action - CTLT",PR Newswire,/news/stocks/rosen-a-top-ranked-firm-encourages-catalent-inc-investors-to-secure-counsel-before-important-april-25-deadline-in-securities-class-action-ctlt-1032233692
263.0,4/17/2023 2:10:37 AM,"Analysts’ Opinions Are Mixed on These Healthcare Stocks: Crispr Therapeutics AG (CRSP), Sarepta Therapeutics (SRPT) and Catalent (CTLT)",TipRanks,/news/stocks/analysts-opinions-are-mixed-on-these-healthcare-stocks-crispr-therapeutics-ag-crsp-sarepta-therapeutics-srpt-and-catalent-ctlt-1032234715
264.0,4/17/2023 7:15:04 AM,Barclays Remains a Hold on Catalent (CTLT),TipRanks,/news/stocks/barclays-remains-a-hold-on-catalent-ctlt-1032235552
265.0,4/17/2023 8:55:05 AM,Robert W. Baird downgrades Catalent (CTLT) to a Hold,TipRanks,/news/stocks/robert-w-baird-downgrades-catalent-ctlt-to-a-hold-1032235705
266.0,4/17/2023 3:21:13 PM,Catalent downgraded at Baird after operational challenges,Seeking Alpha,https://seekingalpha.com/news/3956980-catalent-stock-downgraded-at-baird-on-operational-challenges?utm_source=businessinsider&utm_medium=referral
267.0,4/17/2023 5:00:44 PM,"Benzinga's Top Ratings Upgrades, Downgrades For April 17, 2023",Benzinga,/news/stocks/benzinga-s-top-ratings-upgrades-downgrades-for-april-17-2023-1032236863
268.0,4/17/2023 6:36:07 PM,Catalent falls on report Danaher said to end pursuit,Seeking Alpha,https://seekingalpha.com/news/3957048-catalent-falls-on-report-danaher-said-to-end-pursuit?utm_source=businessinsider&utm_medium=referral
269.0,4/18/2023 1:50:16 AM,"Analysts Are Bullish on Top Healthcare Stocks: Sarepta Therapeutics (SRPT), Catalent (CTLT)",TipRanks,/news/stocks/analysts-are-bullish-on-top-healthcare-stocks-sarepta-therapeutics-srpt-catalent-ctlt-1032237727
270.0,4/22/2023 1:00:00 AM,"CTLT DEADLINE: ROSEN, NATIONAL TRIAL COUNSEL, Encourages Catalent, Inc. Investors with Losses to Secure Counsel Before Important April 25 Deadline in Securities Class Action - CTLT",PR Newswire,/news/stocks/ctlt-deadline-rosen-national-trial-counsel-encourages-catalent-inc-investors-with-losses-to-secure-counsel-before-important-april-25-deadline-in-securities-class-action-ctlt-1032250859
271.0,4/25/2023 10:20:44 AM,"Analysts’ Opinions Are Mixed on These Healthcare Stocks: Catalent (CTLT), Harmony Biosciences Holdings (HRMY) and Foghorn Therapeutics (FHTX)",TipRanks,/news/stocks/analysts-opinions-are-mixed-on-these-healthcare-stocks-catalent-ctlt-harmony-biosciences-holdings-hrmy-and-foghorn-therapeutics-fhtx-1032257634
272.0,4/25/2023 1:53:57 PM,eBay To Rally Around 30%? Here Are 10 Other Analyst Forecasts For Tuesday,Benzinga,/news/stocks/ebay-to-rally-around-30-here-are-10-other-analyst-forecasts-for-tuesday-1032257974
273.0,4/25/2023 11:01:15 PM,Where Catalent Stands With Analysts,Benzinga,/news/stocks/where-catalent-stands-with-analysts-1032260016
274.0,4/28/2023 4:26:51 PM,Catalent gains amid report of cancellation from June conference,Seeking Alpha,https://seekingalpha.com/news/3962194-catalent-gains-amid-report-of-cancellation-from-june-conference?utm_source=businessinsider&utm_medium=referral
275.0,5/8/2023 9:55:21 AM,Catalent tells stockholders to reject TRC Capital's tender offer for shares,Seeking Alpha,https://seekingalpha.com/news/3966896-catalent-tells-stockholders-to-rejects-trc-capitals-offer-for-shares?utm_source=businessinsider&utm_medium=referral
276.0,5/8/2023 12:17:24 PM,"RIOT, MARA and HUT among premarket losers",Seeking Alpha,https://seekingalpha.com/news/3966979-riot-mara-and-hut-among-premarket-losers?utm_source=businessinsider&utm_medium=referral
277.0,5/8/2023 12:30:11 PM,"Catalent plunges ~25% after fiscal '23 revenue outlook cut on productivity, operational woes",Seeking Alpha,https://seekingalpha.com/news/3966984-catalent-stock-falls-as-outlook-cut--productivity-operational-woes?utm_source=businessinsider&utm_medium=referral
278.0,5/8/2023 1:15:07 PM,Stephens Sticks to Their Buy Rating for Catalent (CTLT),TipRanks,/news/stocks/stephens-sticks-to-their-buy-rating-for-catalent-ctlt-1032302559
279.0,5/8/2023 2:03:22 PM,"Immuron, ANI Pharmaceuticals top healthcare gainers; Catalent, Aptorum among losers",Seeking Alpha,https://seekingalpha.com/news/3967072-immuron-ani-pharmaceuticals-top-healthcare-gainers-catalent-aptorum-among-losers?utm_source=businessinsider&utm_medium=referral
280.0,5/8/2023 3:01:13 PM,Here's what Wall Street expects from Catalent's earnings report,Markets Insider Automation,/news/stocks/catalent-quarter-earnings-preview-q3-1032302273
281.0,5/8/2023 3:26:20 PM,Notable earnings before Tuesday's open,Seeking Alpha,https://seekingalpha.com/news/3967129-notable-earnings-before-tuesdays-open?utm_source=businessinsider&utm_medium=referral
282.0,5/8/2023 4:11:37 PM,US Stocks Edge Lower; Tyson Foods Posts Q2 Loss,Benzinga,/news/stocks/us-stocks-edge-lower-tyson-foods-posts-q2-loss-1032302716
283.0,5/8/2023 6:04:20 PM,Crude Oil Rises Over 2%; US Wholesale Inventories Unchanged For March,Benzinga,/news/stocks/crude-oil-rises-over-2-us-wholesale-inventories-unchanged-for-march-1032303008
284.0,5/8/2023 6:10:15 PM,Analysts Have Conflicting Sentiments on These Healthcare Companies: Catalent (CTLT) and BioNTech SE (BNTX),TipRanks,/news/stocks/analysts-have-conflicting-sentiments-on-these-healthcare-companies-catalent-ctlt-and-biontech-se-bntx-1032303325
285.0,5/8/2023 6:30:01 PM,Catalent hits 52-week low as guidance cut prompts BofA to downgrade,Seeking Alpha,https://seekingalpha.com/news/3967346-catalent-stock-hits-52-week-low-bofa-downgrades-guidance-cut?utm_source=businessinsider&utm_medium=referral
286.0,5/8/2023 6:57:38 PM,CTLT Stock Sinks 25% After Catalent Delays Earnings Release,InvestorPlace,/news/stocks/ctlt-stock-sinks-25-after-catalent-delays-earnings-release-1032303432
287.0,5/8/2023 6:59:01 PM,Why Tredegar Shares Are Trading Lower By 15%? Here Are Other Stocks Moving In Monday's Mid-Day Session,Benzinga,/news/stocks/why-tredegar-shares-are-trading-lower-by-15-here-are-other-stocks-moving-in-monday-s-mid-day-session-1032303198
288.0,5/8/2023 8:39:02 PM,Nasdaq Edges Higher; Six Flags Reports Upbeat Results,Benzinga,/news/stocks/nasdaq-edges-higher-six-flags-reports-upbeat-results-1032303392
289.0,5/9/2023 12:10:54 PM,"Analysts Are Bullish on These Healthcare Stocks: Catalent (CTLT), Establishment Labs Holdings (ESTA)",TipRanks,/news/stocks/analysts-are-bullish-on-these-healthcare-stocks-catalent-ctlt-establishment-labs-holdings-esta-1032306500
290.0,5/10/2023 12:39:21 PM,Sarepta on watch as FDA comments on gene therapy ahead of AdCom meeting,Seeking Alpha,https://seekingalpha.com/news/3969046-sarepta-stock-watch-fda-comments-on-gene-therapy?utm_source=businessinsider&utm_medium=referral
291.0,5/11/2023 4:06:30 PM,"Analysts Have Conflicting Sentiments on These Healthcare Companies: Crispr Therapeutics AG (CRSP), Catalent (CTLT) and Syndax Pharmaceuticals (SNDX)",TipRanks,/news/stocks/analysts-have-conflicting-sentiments-on-these-healthcare-companies-crispr-therapeutics-ag-crsp-catalent-ctlt-and-syndax-pharmaceuticals-sndx-1032318895
292.0,5/11/2023 9:58:02 PM,Catalent delaying quarterly report,Seeking Alpha,https://seekingalpha.com/news/3970587-catalent-delaying-quarterly-report?utm_source=businessinsider&utm_medium=referral
293.0,5/12/2023 2:44:38 PM,Notable earnings before Monday's open,Seeking Alpha,https://seekingalpha.com/news/3970857-notable-earnings-before-mondays-open?utm_source=businessinsider&utm_medium=referral
294.0,5/12/2023 6:07:49 PM,"Earnings Week Ahead: Walmart, Home Depot, Alibaba, Cisco, and more",Seeking Alpha,https://seekingalpha.com/news/3970929-earnings-week-ahead-walmart-home-depot-alibaba-cisco-and-more?utm_source=businessinsider&utm_medium=referral
295.0,5/12/2023 7:03:55 PM,Catalent hits new 52-week low; Jefferies defends,Seeking Alpha,https://seekingalpha.com/news/3970999-catalent-stock-hits-52-week-low-jefferies-defends?utm_source=businessinsider&utm_medium=referral
296.0,5/12/2023 10:31:20 PM,Sarepta muscular dystrophy drug SRP-9001 endorsed by FDA advisors,Seeking Alpha,https://seekingalpha.com/news/3971083-sarepta-muscular-dystrophy-drug-srp-9001-endorsed-fda-advisors?utm_source=businessinsider&utm_medium=referral
297.0,5/13/2023 7:06:21 PM,"Catalent delays Q3 earnings release, conference call for third time",Seeking Alpha,https://seekingalpha.com/news/3971098-catalent-delays-q1-earnings-release-conference-call-for-third-time?utm_source=businessinsider&utm_medium=referral
298.0,5/14/2023 3:01:13 PM,Catalent earnings: here's what Wall Street expects,Markets Insider Automation,/news/stocks/catalent-stock-q3-earnings-preview-1032324777
299.0,5/15/2023 11:55:16 AM,Sarepta jumps 29% after FDA panel nod for gene therapy,Seeking Alpha,https://seekingalpha.com/news/3971251-sarepta-stock-jumps-fda-panel-nod-gene-therapy?utm_source=businessinsider&utm_medium=referral
300.0,5/15/2023 3:23:45 PM,Catalent cut to hold at Deutsche Bank on second earnings release delay,Seeking Alpha,https://seekingalpha.com/news/3971442-catalent-cut-hold-deutsche-bank-second-earnings-release-delay?utm_source=businessinsider&utm_medium=referral
301.0,5/15/2023 3:59:13 PM,Catalent cut to hold at Deutsche Bank on third earnings release delay,Seeking Alpha,https://seekingalpha.com/news/3971442-catalent-cut-hold-deutsche-bank-third-earnings-release-delay?utm_source=businessinsider&utm_medium=referral
302.0,5/15/2023 10:01:07 PM,10 Analysts Have This to Say About Catalent,Benzinga,/news/stocks/10-analysts-have-this-to-say-about-catalent-1032328585
303.0,5/18/2023 2:35:25 PM,Catalent Q3 2023 Earnings Preview,Seeking Alpha,https://seekingalpha.com/news/3973069-catalent-q3-2023-earnings-preview?utm_source=businessinsider&utm_medium=referral
304.0,5/19/2023 10:09:17 AM,Catalent Likely To Report Sharp Decline In Q3 Earnings; Here's A Look At Recent Price Target Changes By The Most Accurate Analysts,Benzinga,/news/stocks/catalent-likely-to-report-sharp-decline-in-q3-earnings-here-s-a-look-at-recent-price-target-changes-by-the-most-accurate-analysts-1032339201
305.0,5/19/2023 11:17:53 AM,"Deere, Foot Locker And 3 Stocks To Watch Heading Into Friday",Benzinga,/news/stocks/deere-foot-locker-and-3-stocks-to-watch-heading-into-friday-1032339282
306.0,5/19/2023 12:20:32 PM,"TIO, PHIO and ALIM among pre-market losers",Seeking Alpha,https://seekingalpha.com/news/3973425-tio-phio-and-alim-among-pre-market-losers?utm_source=businessinsider&utm_medium=referral
307.0,5/19/2023 12:44:29 PM,"US Stocks Plunge as Debt-Ceiling Talks Stall, Investors Trim June Hike's Bets: Analyst Calls AI a ""Baby Bubble""",Benzinga,/news/stocks/us-stock-futures-signal-strong-finish-to-week-on-tech-surge-analyst-sees-big-gains-for-year-on-historical-pattern-1032339465
308.0,5/19/2023 12:47:28 PM,"Farfetch, Catalent And Other Big Stocks Moving Higher In Friday's Pre-Market Session",Benzinga,/news/stocks/farfetch-catalent-and-other-big-stocks-moving-higher-in-friday-s-pre-market-session-1032339475
309.0,5/19/2023 2:13:31 PM,Catalent jumps 14% to reverse losses despite guidance cut,Seeking Alpha,https://seekingalpha.com/news/3973409-catalent-stock-slips-after-delaying-q3-report-cuts-outlook?utm_source=businessinsider&utm_medium=referral
310.0,5/19/2023 4:30:44 PM,"CI&T, Globant And Other Big Stocks Moving Higher On Friday",Benzinga,/news/stocks/ci-t-globant-and-other-big-stocks-moving-higher-on-friday-1032340023
311.0,5/19/2023 6:11:04 PM,Hot Stocks: CTLT rises on cost-cutting plan; BE gains on analyst upgrade; DIS and NKE fall,Seeking Alpha,https://seekingalpha.com/news/3973542-hot-stocks-ctlt-rises-on-cost-cutting-plan-be-gains-on-analyst-upgrade-dis-and-nke-fall?utm_source=businessinsider&utm_medium=referral
312.0,5/19/2023 7:21:46 PM,Why Foot Locker Shares Are Trading Lower By Over 25%? Here Are Other Stocks Moving In Friday's Mid-Day Session,Benzinga,/news/stocks/why-foot-locker-shares-are-trading-lower-by-over-25-here-are-other-stocks-moving-in-friday-s-mid-day-session-1032340342
313.0,5/19/2023 7:51:12 PM,Catalent (CTLT) Stock Surges Despite Second Earnings Delay,InvestorPlace,/news/stocks/catalent-ctlt-stock-surges-despite-second-earnings-delay-1032340508
314.0,5/22/2023 1:50:05 AM,Analysts Offer Insights on Healthcare Companies: Catalent (CTLT) and Intercept Pharma (ICPT),TipRanks,/news/stocks/analysts-offer-insights-on-healthcare-companies-catalent-ctlt-and-intercept-pharma-icpt-1032341374
315.0,5/22/2023 9:25:08 AM,Bank of America Securities Keeps Their Sell Rating on Catalent (CTLT),TipRanks,/news/stocks/bank-of-america-securities-keeps-their-sell-rating-on-catalent-ctlt-1032342036
316.0,5/22/2023 12:07:48 PM,"Micron Technology, Niu Technologies And Other Big Stocks Moving Lower In Monday's Pre-Market Session",Benzinga,/news/stocks/micron-technology-niu-technologies-and-other-big-stocks-moving-lower-in-monday-s-pre-market-session-1032342136
317.0,5/22/2023 12:15:27 PM,Jefferies Sticks to Its Buy Rating for Catalent (CTLT),TipRanks,/news/stocks/jefferies-sticks-to-its-buy-rating-for-catalent-ctlt-1032342527
318.0,5/22/2023 5:00:44 PM,"Benzinga's Top Ratings Upgrades, Downgrades For May 22, 2023",Benzinga,/news/stocks/benzinga-s-top-ratings-upgrades-downgrades-for-may-22-2023-1032343045
319.0,5/22/2023 7:00:57 PM,What To Know About JP Morgan's Downgrade of Catalent,Benzinga,/news/stocks/what-to-know-about-jp-morgan-s-downgrade-of-catalent-1032343351
320.0,5/24/2023 12:20:14 PM,"Analysts’ Top Healthcare Picks: Agilent (A), Catalent (CTLT)",TipRanks,/news/stocks/analysts-top-healthcare-picks-agilent-a-catalent-ctlt-1032348350
321.0,5/24/2023 12:22:51 PM,Sarepta says FDA needs more time to review muscular dystrophy drug,Seeking Alpha,https://seekingalpha.com/news/3974552-sarepta-stock-falls-delay-fda-review-gene-therapy?utm_source=businessinsider&utm_medium=referral
322.0,5/26/2023 1:17:17 PM,US Stocks Soar On Debt Ceiling Deal Hopes Despite Fed Hike Risks; Nvidia Eyes $1-Trillion Market Cap On Monster AI Rally,Benzinga,/news/stocks/us-stocks-set-to-open-modestly-higher-as-debt-talks-linger-why-this-analyst-sees-headwinds-easing-1032354121
323.0,6/3/2023 10:00:00 AM,"Earnings Week Ahead: NIO, DocusSgn, GameStop, FuelCell and more",Seeking Alpha,https://seekingalpha.com/news/3977335-earnings-week-ahead-nio-docussgn-gamestop-fuelcell-and-more?utm_source=businessinsider&utm_medium=referral
324.0,6/11/2023 3:01:13 PM,Catalent earnings: here's what to expect,Markets Insider Automation,/news/stocks/catalent-stock-quarter-earnings-preview-q3-1032382087
325.0,6/12/2023 11:03:10 AM,"Catalent Non-GAAP EPS of -$0.09 beats by $0.05, revenue of $1.04B beats by $68.26M",Seeking Alpha,https://seekingalpha.com/news/3979128-catalent-non-gaap-eps-of-0_09-beats-0_05-revenue-of-1_04b-beats-68_26m?utm_source=businessinsider&utm_medium=referral
326.0,6/12/2023 1:47:28 PM,Catalent Inc. Q3 Earnings Summary,RTTNews,/news/stocks/catalent-inc-q3-earnings-summary-1032383262
327.0,6/12/2023 2:02:21 PM,Catalent adds 11% as Q3 report shines after multiple delays,Seeking Alpha,https://seekingalpha.com/news/3979229-catalent-stock-jumps-delayed-q3-report-shines?utm_source=businessinsider&utm_medium=referral
328.0,6/12/2023 3:57:23 PM,Catalent Rises On Better-than-expected Q3 Revenue ,RTTNews,/news/stocks/catalent-rises-on-better-than-expected-q3-revenue-1032383728
329.0,6/12/2023 7:03:58 PM,Why Asset Entities Shares Are Trading Higher By 142%? Here Are Other Stocks Moving In Monday's Mid-Day Session,Benzinga,/news/stocks/why-asset-entities-shares-are-trading-higher-by-142-here-are-other-stocks-moving-in-monday-s-mid-day-session-1032384211
330.0,6/13/2023 8:55:16 AM,Bank of America Securities Reaffirms Their Sell Rating on Catalent (CTLT),TipRanks,/news/stocks/bank-of-america-securities-reaffirms-their-sell-rating-on-catalent-ctlt-1032385319
331.0,6/13/2023 4:00:56 PM,Analyst Ratings for Catalent,Benzinga,/news/stocks/analyst-ratings-for-catalent-1032386391
332.0,6/13/2023 6:51:02 PM,"Catalent 'Is Starting To Move In The Right Direction,' Analyst Says, But Cautions Lack of Visibility for FY24",Benzinga,/news/stocks/catalent-is-starting-to-move-in-the-right-direction-analyst-says-but-cautions-lack-of-visibility-for-fy24-1032386907
333.0,6/14/2023 8:11:09 AM,Catalent regains compliance with NYSE's continued listing standards,Seeking Alpha,https://seekingalpha.com/news/3979718-catalent-regains-compliance-with-nyses-continued-listing-standards?utm_source=businessinsider&utm_medium=referral
334.0,6/14/2023 1:33:52 PM,Catalent downgraded to hold at Jefferies on growth concerns,Seeking Alpha,https://seekingalpha.com/news/3979822-catalent-downgraded-hold-jefferies-growth-concerns?utm_source=businessinsider&utm_medium=referral
335.0,6/14/2023 2:42:12 PM,Advanced Micro Devices To Rally Around 17%? Here Are 10 Other Analyst Forecasts For Wednesday,Benzinga,/news/stocks/advanced-micro-devices-to-rally-around-17-here-are-10-other-analyst-forecasts-for-wednesday-1032388907
336.0,6/14/2023 5:01:58 PM,"Benzinga's Top Ratings Upgrades, Downgrades For June 14, 2023",Benzinga,/news/stocks/benzinga-s-top-ratings-upgrades-downgrades-for-june-14-2023-1032389437
337.0,6/16/2023 2:45:50 PM,Maravai LifeSciences gains amid report of latest takeover interest,Seeking Alpha,https://seekingalpha.com/news/3980510-maravai-lifesciences-gains-amid-report-of-takeover-interest?utm_source=businessinsider&utm_medium=referral
338.0,6/16/2023 10:20:23 PM,"Top 5 Performing S&P 500 Stocks This Week: 2 Are AI Latecomers, 1 Was Nearly Sunk By Covid",Benzinga,/news/etf/top-5-performing-s-p-500-stocks-this-week-2-are-ai-latecomers-1-was-nearly-sunk-by-covid-1032395164
339.0,6/20/2023 8:24:57 PM,Catalent names Matti Masanovich new finance chief,Seeking Alpha,https://seekingalpha.com/news/3981142-catalent-names-matti-masanovich-new-finance-chief?utm_source=businessinsider&utm_medium=referral
340.0,6/21/2023 4:25:55 PM,Stephens Reaffirms Their Buy Rating on Catalent (CTLT),TipRanks,/news/stocks/stephens-reaffirms-their-buy-rating-on-catalent-ctlt-1032402566
341.0,6/22/2023 12:20:07 PM,Analysts Offer Insights on Healthcare Companies: Qiagen (QGEN) and Catalent (CTLT),TipRanks,/news/stocks/analysts-offer-insights-on-healthcare-companies-qiagen-qgen-and-catalent-ctlt-1032404428
342.0,6/22/2023 6:41:29 PM,"Sarepta Duchenne treatment wins FDA nod, but with smaller population (update)",Seeking Alpha,https://seekingalpha.com/news/3982028-sarepta-duchenne-treatment-wins-fda-nod-but--smaller-population?utm_source=businessinsider&utm_medium=referral
343.0,6/23/2023 8:59:05 AM,Goldman adds 25 new stocks with growth potential to its ROE basket,Seeking Alpha,https://seekingalpha.com/news/3981981-goldman-balances-return-on-equity-growth-baskets-adds-25-new-stocks-with-growth-potential?utm_source=businessinsider&utm_medium=referral
344.0,6/27/2023 7:18:00 PM,Regeneron falls as FDA rejects high-dose Eylea (update),Seeking Alpha,https://seekingalpha.com/news/3983374-regeneron-high-dose-eylea-rejected-by-fda?utm_source=businessinsider&utm_medium=referral
345.0,6/28/2023 2:42:32 PM,Catalent confirmed as manufacturer of Regeneron’s high-dose Eylea rejected by FDA,Seeking Alpha,https://seekingalpha.com/news/3983718-catalent-linked-fda-snub-regenerons-high-dose-eylea?utm_source=businessinsider&utm_medium=referral
346.0,6/30/2023 4:16:12 PM,Stephens Remains a Buy on Catalent (CTLT),TipRanks,/news/stocks/stephens-remains-a-buy-on-catalent-ctlt-1032421214
347.0,6/30/2023 9:00:48 PM,Analyst Ratings for Catalent,Benzinga,/news/stocks/analyst-ratings-for-catalent-1032421477
348.0,7/1/2023 1:50:12 AM,Analysts Have Conflicting Sentiments on These Healthcare Companies: Neurocrine (NBIX) and Catalent (CTLT),TipRanks,/news/stocks/analysts-have-conflicting-sentiments-on-these-healthcare-companies-neurocrine-nbix-and-catalent-ctlt-1032421755
349.0,7/13/2023 11:21:28 AM,"Analysts Offer Insights on Healthcare Companies: CVS Health (CVS), RegenXBio (RGNX) and Catalent (CTLT)",TipRanks,/news/stocks/analysts-offer-insights-on-healthcare-companies-cvs-health-cvs-regenxbio-rgnx-and-catalent-ctlt-1032444143
350.0,7/20/2023 2:37:19 AM,Catalent gains after report of activist Elliott taking stake,Seeking Alpha,https://seekingalpha.com/news/3989007-catalent-gains-after-report-of-activist-elliott-taking-stake?utm_source=businessinsider&utm_medium=referral
351.0,7/20/2023 1:12:49 PM,CTLT Stock Alert: What to Know as Elliott Takes a Stake in Catalent,InvestorPlace,/news/stocks/ctlt-stock-alert-what-to-know-as-elliott-takes-a-stake-in-catalent-1032462655
352.0,7/20/2023 1:24:39 PM,NVDA Stock Alert; Wolfe Research Just Gave Nvidia a Big Vote of Confidence,InvestorPlace,/news/stocks/nvda-stock-alert-wolfe-research-just-gave-nvidia-a-big-vote-of-confidence-1032462653
353.0,7/20/2023 2:44:16 PM,Catalent gains amid report of Elliott stake; RBC sees multiple paths for activist,Seeking Alpha,https://seekingalpha.com/news/3989234-catalent-gains-amid-report-of-elliott-stake-rbc-sees-multiple-paths-for-activist?utm_source=businessinsider&utm_medium=referral
354.0,7/20/2023 2:48:21 PM,"Biggest stock movers today: Netflix, American Airlines, Johnson & Johnson and more",Seeking Alpha,https://seekingalpha.com/news/3989052-biggest-stock-movers-today-tesla-discover-financial-services-and-more?utm_source=businessinsider&utm_medium=referral
355.0,7/20/2023 5:00:43 PM,"Benzinga's Top Ratings Upgrades, Downgrades For July 20, 2023",Benzinga,/news/stocks/benzinga-s-top-ratings-upgrades-downgrades-for-july-20-2023-1032463247
356.0,7/21/2023 1:46:26 AM,Catalent (CTLT) Gets a Buy from RBC Capital,TipRanks,/news/stocks/catalent-ctlt-gets-a-buy-from-rbc-capital-1032464207
357.0,8/1/2023 1:44:50 PM,Hedge fund Third Point reducing single name short positions,Seeking Alpha,https://seekingalpha.com/news/3994180-hedge-fund-third-point-reducing-single-name-short-positions?utm_source=businessinsider&utm_medium=referral
358.0,8/3/2023 1:46:36 AM,RBC Capital Sticks to Its Buy Rating for Catalent (CTLT),TipRanks,/news/stocks/rbc-capital-sticks-to-its-buy-rating-for-catalent-ctlt-1032509196
359.0,8/3/2023 12:00:28 PM,Regeneron gains after Q2 beat; FDA action on high-dose Eylea expected in Q3,Seeking Alpha,https://seekingalpha.com/news/3996461-regeneron-stock-gains-after-q2-beat?utm_source=businessinsider&utm_medium=referral
360.0,8/3/2023 7:17:40 PM,MindMed inks licensing deal with Catalent for drug technology,Seeking Alpha,https://seekingalpha.com/news/3996875-mindmed-stock-gains-licensing-deal-catalent?utm_source=businessinsider&utm_medium=referral
361.0,8/14/2023 9:00:53 PM,"Corvex Management adds Catalent, exits California Resources",Seeking Alpha,https://seekingalpha.com/news/4002607-corvex-management-adds-catalent-exits-california-resources?utm_source=businessinsider&utm_medium=referral
362.0,8/14/2023 9:58:46 PM,Catalent accused of misleading investors in shareholder suit,Seeking Alpha,https://seekingalpha.com/news/4002679-catalent-accused-misleading-investors-shareholder-suit?utm_source=businessinsider&utm_medium=referral
363.0,8/15/2023 5:00:50 PM,What 19 Analyst Ratings Have To Say About Catalent,Benzinga,/news/stocks/what-19-analyst-ratings-have-to-say-about-catalent-1032556016
364.0,8/15/2023 7:44:44 PM,Regeneron could see share price bounce with potential approvals,Seeking Alpha,https://seekingalpha.com/news/4003175-regeneron-could-see-share-price-bounce-potential-approvals?utm_source=businessinsider&utm_medium=referral
365.0,8/23/2023 1:00:14 PM,Novo Nordisk said to have added Thermo Fisher for Wegovy production,Seeking Alpha,https://seekingalpha.com/news/4005499-novo-nordisk-taps-thermo-fisher-wegovy-production?utm_source=businessinsider&utm_medium=referral
366.0,8/25/2023 12:20:18 PM,"Analysts Are Bullish on Top Healthcare Stocks: Axsome Therapeutics (AXSM), Catalent (CTLT)",TipRanks,/news/stocks/analysts-are-bullish-on-top-healthcare-stocks-axsome-therapeutics-axsm-catalent-ctlt-1032582544
367.0,8/25/2023 5:30:13 PM,Novo Nordisk chief 'confident' Catalent Wegovy issues will be fixed - report,Seeking Alpha,https://seekingalpha.com/news/4006508-novo-nordisk-chief-confident-catalent-wegovy-issues-fixed?utm_source=businessinsider&utm_medium=referral
368.0,8/28/2023 2:53:15 PM,Notable earnings before Tuesday's open,Seeking Alpha,https://seekingalpha.com/news/4006750-notable-earnings-before-tuesdays-open?utm_source=businessinsider&utm_medium=referral
369.0,8/28/2023 3:01:13 PM,Here's what to expect from Catalent's earnings report,Markets Insider Automation,/news/stocks/catalent-stock-price-q4-earnings-preview-1032585904
370.0,8/28/2023 4:25:03 PM,Catalent Q4 2023 Earnings Preview,Seeking Alpha,https://seekingalpha.com/news/4006785-catalent-q4-2023-earnings-preview?utm_source=businessinsider&utm_medium=referral
371.0,8/28/2023 9:19:37 PM,Catalent nears settlement with activist Elliott for board seats - report,Seeking Alpha,https://seekingalpha.com/news/4006877-catalent-nears-settlement-with-activist-elliott-for-board-seats-report?utm_source=businessinsider&utm_medium=referral
372.0,8/29/2023 11:04:51 AM,"Catalent Non-GAAP EPS of $0.09 misses by $0.01, revenue of $1.07B beats by $20M",Seeking Alpha,https://seekingalpha.com/news/4006952-catalent-non-gaap-eps-of-0_09-misses-0_01-revenue-of-1_07b-beats-20m?utm_source=businessinsider&utm_medium=referral
373.0,8/29/2023 1:49:39 PM,"Catalent gains as it enters pact with activist Elliott, to conduct business review (update)",Seeking Alpha,https://seekingalpha.com/news/4006971-catalent-enters-cooperation-pact-with-activist-elliott-to-conduct-business-review?utm_source=businessinsider&utm_medium=referral
374.0,8/29/2023 1:55:13 PM,Catalent (CTLT) Stock Gains on Elliott Deal,InvestorPlace,/news/stocks/catalent-ctlt-stock-gains-on-elliott-deal-1032589304
375.0,8/29/2023 1:57:24 PM,Catalent Enters Into Agreement With Activist Elliott For Board Seats; Stock Up In Pre-market ,RTTNews,/news/stocks/catalent-enters-into-agreement-with-activist-elliott-for-board-seats-stock-up-in-pre-market-1032588688
376.0,8/29/2023 2:17:35 PM,ORCL Stock Alert: Can AI Hype Really Boost Oracle 20%?,InvestorPlace,/news/stocks/orcl-stock-alert-can-ai-hype-really-boost-oracle-20-1032589732
377.0,8/29/2023 2:33:18 PM,Can a New CFO Save Canoo (GOEV) Stock?,InvestorPlace,/news/stocks/can-a-new-cfo-save-canoo-goev-stock-1032589783
378.0,8/29/2023 2:47:30 PM,Workhorse Fails to Get Enough Votes to Increase WKHS Stock Count,InvestorPlace,/news/stocks/workhorse-fails-to-get-enough-votes-to-increase-wkhs-stock-count-1032589824
379.0,8/30/2023 10:35:14 AM,Catalent (CTLT) Gets a Buy from RBC Capital,TipRanks,/news/stocks/catalent-ctlt-gets-a-buy-from-rbc-capital-1032592191
380.0,8/30/2023 7:00:28 PM,RBC Capital Maintains Outperform Rating for Catalent: Here's What You Need To Know,Benzinga,/news/stocks/rbc-capital-maintains-outperform-rating-for-catalent-here-s-what-you-need-to-know-1032593903
381.0,8/30/2023 7:27:47 PM,"Catalent's Activist Board Presence To Boost Operational Recovery, Analyst Says",Benzinga,/news/stocks/catalent-s-activist-board-presence-to-boost-operational-recovery-analyst-says-1032593978
382.0,8/30/2023 8:45:04 PM,Catalent to delay filing annual report,Seeking Alpha,https://seekingalpha.com/news/4007718-catalent-delay-filing-annual-report?utm_source=businessinsider&utm_medium=referral
383.0,8/31/2023 4:20:37 AM,"Analysts Offer Insights on Healthcare Companies: Catalent (CTLT), Pfizer (PFE) and Humana (HUM)",TipRanks,/news/stocks/analysts-offer-insights-on-healthcare-companies-catalent-ctlt-pfizer-pfe-and-humana-hum-1032594626
384.0,8/31/2023 9:01:46 AM,"Analysts Offer Insights on Healthcare Companies: Chemed (CHE), Phibro Animal Health (PAHC) and Catalent (CTLT)",TipRanks,/news/stocks/analysts-offer-insights-on-healthcare-companies-chemed-che-phibro-animal-health-pahc-and-catalent-ctlt-1032595457
385.0,8/31/2023 4:00:40 PM,15 Analysts Have This to Say About Catalent,Benzinga,/news/stocks/15-analysts-have-this-to-say-about-catalent-1032596814
386.0,9/5/2023 5:00:45 PM,"Benzinga's Top Ratings Upgrades, Downgrades For September 5, 2023",Benzinga,/news/stocks/benzinga-s-top-ratings-upgrades-downgrades-for-september-5-2023-1032606125
387.0,9/7/2023 4:42:08 PM,3 Debt-Ridden S&P 500 Stocks to Sell Before It’s Too Late,InvestorPlace,/news/stocks/3-debt-ridden-sp-500-stocks-to-sell-before-its-too-late-1032614003
388.0,9/15/2023 10:46:50 AM,Three stocks strategies heading into Q4 from Goldman,Seeking Alpha,https://seekingalpha.com/news/4010492-three-stocks-strategies-going-heading-into-q4-from-goldman?utm_source=businessinsider&utm_medium=referral&feed_item_type=news
389.0,9/29/2023 5:00:51 PM,Analyst Ratings for Catalent,Benzinga,/news/stocks/analyst-ratings-for-catalent-1032667065
390.0,10/31/2023 9:56:40 AM,Buy Rating on Catalent Inc. Supported by Promising EMBARK Results and Positive FDA Outlook,TipRanks,/news/stocks/buy-rating-on-catalent-inc-supported-by-promising-embark-results-and-positive-fda-outlook-1032761375
391.0,10/31/2023 11:27:23 AM,Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday,InvestorPlace,/news/stocks/todays-biggest-pre-market-stock-movers-10-top-gainers-and-losers-on-tuesday-oct-31st-1032758806
392.0,10/31/2023 4:55:57 PM,Hold Rating on Catalent Amid Market Pullback and Operational Challenges: An Analysis by Eric Coldwell,TipRanks,/news/stocks/hold-rating-on-catalent-amid-market-pullback-and-operational-challenges-an-analysis-by-eric-coldwell-1032761859
393.0,10/31/2023 6:36:44 PM,Why JetBlue Airways Shares Are Trading Lower By Around 14%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session,Benzinga,/news/stocks/why-jetblue-airways-shares-are-trading-lower-by-around-14-here-are-other-stocks-moving-in-tuesday-s-mid-day-session-1032760861
394.0,10/31/2023 8:03:24 PM,What's Going On With Biotech Contract Service Firm Catalent Stock Today?,Benzinga,/news/stocks/what-s-going-on-with-biotech-contract-service-firm-catalent-stock-today-1032761002
395.0,11/14/2023 2:15:39 PM,Catalent’s Mixed Performance and Revenue Projections Lead to Hold Rating: An Analyst’s Perspective,TipRanks,/news/stocks/catalent-s-mixed-performance-and-revenue-projections-lead-to-hold-rating-an-analyst-s-perspective-1032819931
396.0,11/14/2023 3:01:13 PM,Catalent is about to announce its earnings — here's what to expect,Markets Insider Automation,/news/stocks/catalent-q1-quarterly-earnings-preview-stock-1032817817
397.0,11/15/2023 1:49:20 PM,Catalent Posts Adj. Loss In Preliminary Q1; Organic Net Revenue Down 8% ,RTTNews,/news/stocks/catalent-posts-adj-loss-in-preliminary-q1-organic-net-revenue-down-8-1032822551
398.0,11/15/2023 3:59:05 PM,Catalent Shares Rise After Preliminary Q1 Results Beat Analysts' View ,RTTNews,/news/stocks/catalent-shares-rise-after-preliminary-q1-results-beat-analysts-view-1032823385
399.0,11/15/2023 5:08:04 PM,"Target Reports Earnings Beat, Joins AST SpaceMobile, Dada Nexus And Other Big Stocks Moving Higher On Wednesday",Benzinga,/news/stocks/target-reports-earnings-beat-joins-ast-spacemobile-dada-nexus-and-other-big-stocks-moving-higher-on-wednesday-1032823974
400.0,11/15/2023 6:22:09 PM,"Stocks Inch Higher On Soft PPI, 'Magnificent 7' Retest 2021 Record Highs: What's Driving Markets Wednesday?",Benzinga,/news/etf/stocks-inch-higher-on-soft-ppi-magnificent-seven-retest-2021-record-highs-what-s-driving-markets-wednesday-1032824192
401.0,11/15/2023 8:26:49 PM,Catalent's Q1 Performance Beat Expectations: Analyst Says Main Focus On Manufacturing Outlook For Sarepta's Gene Therapy,Benzinga,/news/stocks/catalent-s-q1-performance-beat-expectations-analyst-says-main-focus-on-manufacturing-outlook-for-sarepta-s-gene-therapy-1032824433
402.0,11/16/2023 1:26:26 AM,Catalent’s Uncertain Mid-Term Trajectory and Valuation Concerns: An Analysis by Derik De Bruin,TipRanks,/news/stocks/catalent-s-uncertain-mid-term-trajectory-and-valuation-concerns-an-analysis-by-derik-de-bruin-1032827501
403.0,11/16/2023 9:26:29 AM,Optimistic Future Growth Prospects for Catalent: A comprehensive Analysis by Eric Coldwell,TipRanks,/news/stocks/optimistic-future-growth-prospects-for-catalent-a-comprehensive-analysis-by-eric-coldwell-1032829266
404.0,11/16/2023 12:01:47 PM,Analysts’ Opinions Are Mixed on These Healthcare Stocks: MoonLake Immunotherapeutics (MLTX) and Catalent (CTLT),TipRanks,/news/stocks/analysts-opinions-are-mixed-on-these-healthcare-stocks-moonlake-immunotherapeutics-mltx-and-catalent-ctlt-1032829503
405.0,11/16/2023 12:05:52 PM,Hold Rating on Catalent’s Stock: Balancing Recurring Revenue Prospects with Challenges in Biologics Sector,TipRanks,/news/stocks/hold-rating-on-catalent-s-stock-balancing-recurring-revenue-prospects-with-challenges-in-biologics-sector-1032829502
406.0,11/16/2023 2:00:51 PM,What 9 Analyst Ratings Have To Say About Catalent,Benzinga,/news/stocks/what-9-analyst-ratings-have-to-say-about-catalent-1032827395
407.0,11/16/2023 2:07:18 PM,Intel To Rally Over 23%? Here Are 10 Top Analyst Forecasts For Thursday,Benzinga,/news/stocks/intel-to-rally-over-23-here-are-10-top-analyst-forecasts-for-thursday-1032827464
408.0,12/15/2023 8:03:05 AM,"Analysts Offer Insights on Healthcare Companies: Legend Biotech (LEGN), Catalent (CTLT) and Vertex Pharmaceuticals (VRTX)",TipRanks,/news/stocks/analysts-offer-insights-on-healthcare-companies-legend-biotech-legn-catalent-ctlt-and-vertex-pharmaceuticals-vrtx-1032905951
409.0,1/11/2024 6:48:33 AM,Strong Buy Rating for Catalent Backed by Growth in Biopharma Contracting and Robust Pipeline,TipRanks,/news/stocks/strong-buy-rating-for-catalent-backed-by-growth-in-biopharma-contracting-and-robust-pipeline-1032959850
410.0,1/19/2024 10:03:58 PM,S&P 500 Shatters Records: The Top-Performing Stocks In January 2024,Benzinga,/news/etf/s-p-500-shatters-records-the-top-performing-stocks-in-january-2024-1032981017
411.0,1/25/2024 4:00:32 PM,Analyst Expectations For Catalent's Future,Benzinga,/news/stocks/analyst-expectations-for-catalent-s-future-1032997476
412.0,1/30/2024 12:12:35 PM,"Analysts’ Top Healthcare Picks: Hookipa Pharma (HOOK), Catalent (CTLT)",TipRanks,/news/stocks/analysts-top-healthcare-picks-hookipa-pharma-hook-catalent-ctlt-1033010844
413.0,2/5/2024 11:39:48 AM,Catalent to be acquired by Novo Holdings in $16.5B deal,Seeking Alpha,https://seekingalpha.com/news/4062457-catalent-acquired-novo-holdings-165b-deal?utm_source=businessinsider&utm_medium=referral&feed_item_type=news
414.0,2/5/2024 12:20:47 PM,Novo Holdings To Acquire Catalent ,RTTNews,/news/stocks/novo-holdings-to-acquire-catalent-1033029443
415.0,2/5/2024 12:25:31 PM,Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday,InvestorPlace,/news/stocks/todays-biggest-pre-market-stock-movers-10-top-gainers-and-losers-on-monday-feb-5th-1033029738
416.0,2/5/2024 1:31:42 PM,"CTLT, BTAI and CAMP are among pre market gainers",Seeking Alpha,https://seekingalpha.com/news/4062535-ctlt-btai-and-camp-are-among-pre-market-gainers?utm_source=businessinsider&utm_medium=referral&feed_item_type=news
417.0,2/5/2024 3:06:09 PM,"Biggest stock movers today: Nvidia, Air Products and Chemicals, Estee Lauder, 4D Molecular Therapeutics, and more",Seeking Alpha,https://seekingalpha.com/news/4062421-biggest-stock-movers-today?utm_source=businessinsider&utm_medium=referral&feed_item_type=news
418.0,2/5/2024 3:51:44 PM,Eli Lilly sees highest intraday trade since November ahead of earnings,Seeking Alpha,https://seekingalpha.com/news/4062641-eli-lilly-sees-highest-intraday-trade-since-november-ahead-of-earnings?utm_source=businessinsider&utm_medium=referral&feed_item_type=news
419.0,2/5/2024 3:57:46 PM,Catalent (CTLT) Stock Pops 10% on Sale to Novo Nordisk,InvestorPlace,/news/stocks/catalent-ctlt-stock-pops-10-on-sale-to-novo-nordisk-1033031023
420.0,2/5/2024 4:32:52 PM,"Estée Lauder Posts Upbeat Earnings, Joins ON Semiconductor, Tyson Foods And Other Big Stocks Moving Higher On Monday",Benzinga,/news/stocks/estée-lauder-posts-upbeat-earnings-joins-on-semiconductor-tyson-foods-and-other-big-stocks-moving-higher-on-monday-1033030909
421.0,2/5/2024 5:38:30 PM,Eli Lilly Q4 results to highlight Zepbound uptake,Seeking Alpha,https://seekingalpha.com/news/4062717-eli-lilly-q4-results-highlight-zepbound-uptake?utm_source=businessinsider&utm_medium=referral&feed_item_type=news
422.0,2/5/2024 6:56:50 PM,Why Air Products and Chemicals Shares Are Trading Lower By Around 15%? Here Are Other Stocks Moving In Monday's Mid-Day Session,Benzinga,/news/stocks/why-air-products-and-chemicals-shares-are-trading-lower-by-around-15-here-are-other-stocks-moving-in-monday-s-mid-day-session-1033031395
423.0,2/5/2024 8:12:09 PM,"Stocks Fall As Traders Dial Back Rate Cut Bets; Dollar, Treasury Yields Rise: What's Driving Markets Monday?",Benzinga,/news/stocks/stocks-fall-as-traders-dial-back-rate-cut-bets-dollar-treasury-yields-rise-what-s-driving-markets-monday-1033031539
424.0,2/5/2024 8:46:06 PM,Novo-Catalent deal to ease Wegovy supply concerns,Seeking Alpha,https://seekingalpha.com/news/4062824-novo-catalent-deal-ease-wegovy-supply-concerns?utm_source=businessinsider&utm_medium=referral&feed_item_type=news
425.0,2/6/2024 6:25:57 AM,Barclays Sticks to Their Hold Rating for Catalent (CTLT),TipRanks,/news/stocks/barclays-sticks-to-their-hold-rating-for-catalent-ctlt-1033033879
426.0,2/6/2024 9:12:17 AM,"Catalent Finalizes Strategic Merger with Creek Parent, Inc.",TipRanks,/news/stocks/catalent-finalizes-strategic-merger-with-creek-parent-inc-1033034391
427.0,2/6/2024 9:12:30 AM,Catalent Announces Strategic Merger Agreement with Novo Holdings,TipRanks,/news/stocks/catalent-announces-strategic-merger-agreement-with-novo-holdings-1033034390
428.0,2/6/2024 1:54:09 PM,Uber To Rally Around 15%? Here Are 10 Top Analyst Forecasts For Tuesday,Benzinga,/news/stocks/uber-to-rally-around-15-here-are-10-top-analyst-forecasts-for-tuesday-1033034665
429.0,2/6/2024 2:22:14 PM,Catalent Analysts Raise Their Forecasts Following Acquisition News,Benzinga,/news/stocks/catalent-analysts-raise-their-forecasts-following-acquisition-news-1033034919
430.0,2/6/2024 6:23:49 PM,Lilly reportedly worried about impact of Catalent/Novo deal,Seeking Alpha,https://seekingalpha.com/news/4063363-lilly-reportedly-worried-about-impact-of-catalent-novo-deal?utm_source=businessinsider&utm_medium=referral&feed_item_type=news
431.0,2/6/2024 7:48:01 PM,"Eli Lilly, Novo Nordisk Could Be First Trillion-Dollar Drug Stocks",InvestorPlace,/news/stocks/eli-lilly-novo-nordisk-could-be-first-trillion-dollar-drug-stocks-1033036679
432.0,2/6/2024 9:16:24 PM,Catalent ticks lower amid report Indiana plant may have quality issues,Seeking Alpha,https://seekingalpha.com/news/4063443-catalent-ticks-lower-amid-report-indiana-plant-may-have-quality-issues?utm_source=businessinsider&utm_medium=referral&feed_item_type=news
433.0,2/7/2024 1:35:55 PM,Analyst Maintains Hold Rating Amid Catalent’s Strategic Acquisition and Complex Valuation,TipRanks,/news/stocks/analyst-maintains-hold-rating-amid-catalent-s-strategic-acquisition-and-complex-valuation-1033042116
434.0,2/7/2024 10:43:49 PM,EU drug regulators to assess potential impact of Catalent-Novo merger,Seeking Alpha,https://seekingalpha.com/news/4064289-eu-drug-regulators-to-assess-potential-impact-of-catalent-novo-merger?utm_source=businessinsider&utm_medium=referral&feed_item_type=news
435.0,2/8/2024 3:01:13 PM,What Wall Street expects from Catalent's earnings,Markets Insider Automation,/news/stocks/catalent-stock-price-quarter-earnings-preview-q2-1033046498
436.0,2/8/2024 3:30:49 PM,Notable earnings before Friday's open,Seeking Alpha,https://seekingalpha.com/news/4064743-notable-earnings-before-fridays-open?utm_source=businessinsider&utm_medium=referral&feed_item_type=news
437.0,2/8/2024 4:38:41 PM,Catalent Q2 2024 Earnings Preview,Seeking Alpha,https://seekingalpha.com/news/4064693-catalent-q2-2024-earnings-preview?utm_source=businessinsider&utm_medium=referral&feed_item_type=news
438.0,2/9/2024 1:02:43 PM,"Catalent Non-GAAP EPS of -$0.24 misses by $0.22, revenue of $1.03B beats by $20M",Seeking Alpha,https://seekingalpha.com/news/4065080-catalent-non-gaap-eps-of-0_24-misses-0_22-revenue-of-1_03b-beats-20m?utm_source=businessinsider&utm_medium=referral&feed_item_type=news
439.0,2/9/2024 2:42:11 PM,Catalent Posts Wider-than-expected Q2 Loss; Revenues Down ,RTTNews,/news/stocks/catalent-posts-wider-than-expected-q2-loss-revenues-down-1033051094
440.0,2/9/2024 6:21:35 PM,AstraZeneca looking to ramp up in-house production amid Catalent deal,Seeking Alpha,https://seekingalpha.com/news/4065249-astrazeneca-looking-to-ramp-up-in-house-production-amid-catalent-deal?utm_source=businessinsider&utm_medium=referral&feed_item_type=news
441.0,2/9/2024 6:39:14 PM,FTC likely to look at Catalent alternatives in review of Novo deal - report,Seeking Alpha,https://seekingalpha.com/news/4065255-ftc-likely-to-look-at-catalent-alternatives-in-review-of-novo-deal-report?utm_source=businessinsider&utm_medium=referral&feed_item_type=news
442.0,2/12/2024 8:46:16 AM,Catalent (CTLT) Gets a Hold from Barclays,TipRanks,/news/stocks/catalent-ctlt-gets-a-hold-from-barclays-1033056530
443.0,2/12/2024 1:20:16 PM,"Analysts Offer Insights on Healthcare Companies: Exelixis (EXEL), BeiGene (BGNE) and Catalent (CTLT)",TipRanks,/news/stocks/analysts-offer-insights-on-healthcare-companies-exelixis-exel-beigene-bgne-and-catalent-ctlt-1033057865
444.0,2/12/2024 1:41:44 PM,Novo Nordisk’s parent eyes $7B annual investments by 2030: FT,Seeking Alpha,https://seekingalpha.com/news/4065481-novo-nordisks-parent-eyes-7b-annual-investments-2030?utm_source=businessinsider&utm_medium=referral&feed_item_type=news
445.0,2/14/2024 8:01:23 PM,Catalent gains after filing 10-Q,Seeking Alpha,https://seekingalpha.com/news/4067068-catalent-gains-after-filing-10-q?utm_source=businessinsider&utm_medium=referral&feed_item_type=news
446.0,2/20/2024 8:00:47 PM,In-Depth Examination Of 5 Analyst Recommendations For Catalent,Benzinga,/news/stocks/in-depth-examination-of-5-analyst-recommendations-for-catalent-1033084644
447.0,2/26/2024 5:31:36 PM,"Eli Lilly, Novo Nordisk's Strategies Against New Weight-Loss Drug Competitors",Benzinga,/news/etf/eli-lilly-novo-nordisk-s-strategies-against-new-weight-loss-drug-competitors-1033103712
448.0,2/27/2024 9:00:02 PM,"Waters, Moderna most shorted stocks in S&P 500 health sector till Jan-end",Seeking Alpha,https://seekingalpha.com/news/4072568-waters-moderna-most-shorted-stocks-in-sp-500-health-sector-till-jan-end?utm_source=businessinsider&utm_medium=referral&feed_item_type=news
449.0,2/29/2024 11:00:45 PM,Top Stocks Not Named Nvidia You Need To Know About In 2024: Here's What Investors Think About Them (Wall Street Vs. Reddit),Benzinga,/news/stocks/top-stocks-not-named-nvidia-you-need-to-know-about-in-2024-here-s-what-investors-think-about-them-wall-street-vs-reddit-1033120683
450.0,3/1/2024 10:05:12 PM,"Record-High S&P 500 Propels SPY ETF To $500-Billion Milestone, Nvidia Tops $2 Trillion, Broadcom Surpasses Tesla",Benzinga,/news/etf/record-high-s-p-500-propels-spy-etf-to-500-billion-milestone-nvidia-tops-2-trillion-broadcom-surpasses-tesla-1033125195
451.0,3/5/2024 6:23:30 AM,"Analysts Offer Insights on Healthcare Companies: Arbutus Biopharma (ABUS), Twist Bioscience (TWST) and Catalent (CTLT)",TipRanks,/news/stocks/analysts-offer-insights-on-healthcare-companies-arbutus-biopharma-abus-twist-bioscience-twst-and-catalent-ctlt-1033131800
452.0,3/5/2024 6:02:26 PM,"Eli Lilly said to have tapped National Resilience, BSP for Zepbound production",Seeking Alpha,https://seekingalpha.com/news/4076137-eli-lilly-taps-national-resilience-bsp-make-zepbound?utm_source=businessinsider&utm_medium=referral&feed_item_type=news
453.0,3/8/2024 5:10:25 PM,Novo Nordisk not planning more supply chain acquisitions: report,Seeking Alpha,https://seekingalpha.com/news/4077703-novo-nordisk-not-planning-more-supply-chain-acquisitions-report?utm_source=businessinsider&utm_medium=referral&feed_item_type=news
454.0,3/9/2024 6:00:00 PM,The Top 3 Pharma Stocks to Buy in March 2024,InvestorPlace,/news/stocks/the-top-3-pharma-stocks-to-buy-in-march2024-1033148079
455.0,3/30/2024 4:13:00 PM,Eli Lilly tops S&P 500 healthcare sector in Q1 as weight loss frenzy continues,Seeking Alpha,https://seekingalpha.com/news/4084974-eli-lilly-tops-the-growth-chart-for-the-sp-500-index-in-q1-as-the-sector-gains-momentum?utm_source=businessinsider&utm_medium=referral&feed_item_type=news
456.0,4/4/2024 5:01:08 PM,Beyond The Numbers: 6 Analysts Discuss Catalent Stock,Benzinga,/news/stocks/beyond-the-numbers-6-analysts-discuss-catalent-stock-1033223169
457.0,4/5/2024 7:50:31 AM,"Analysts Have Conflicting Sentiments on These Healthcare Companies: Catalent (CTLT), Alvotech (ALVO) and Immunocore Holdings (IMCR)",TipRanks,/news/stocks/analysts-have-conflicting-sentiments-on-these-healthcare-companies-catalent-ctlt-alvotech-alvo-and-immunocore-holdings-imcr-1033225309
458.0,4/10/2024 6:56:07 PM,Top 10 best performing S&P 500 health care stocks of 2024,Seeking Alpha,https://seekingalpha.com/news/4088691-top-10-best-performing-sp-500-health-care-stocks-of-2024?utm_source=businessinsider&utm_medium=referral&feed_item_type=news
459.0,4/12/2024 5:41:03 AM,"Analysts Offer Insights on Healthcare Companies: Catalent (CTLT), Vertex Pharmaceuticals (VRTX) and Alkermes (ALKS)",TipRanks,/news/stocks/analysts-offer-insights-on-healthcare-companies-catalent-ctlt-vertex-pharmaceuticals-vrtx-and-alkermes-alks-1033243485
460.0,5/3/2024 1:26:24 PM,"Catalent, Novo Nordisk receive FTC request for more information",Seeking Alpha,https://seekingalpha.com/news/4099626-catalent-novo-nordisk-receive-ftc-requet-for-more-information?utm_source=businessinsider&utm_medium=referral&feed_item_type=news
461.0,5/8/2024 9:40:18 PM,"Catalent Non-GAAP EPS of -$0.06 misses by $0.29, revenue of $1.07B misses by $50M",Seeking Alpha,https://seekingalpha.com/news/4103247-catalent-non-gaap-eps-of-0_06-misses-0_29-revenue-of-1_07b-misses-50m?utm_source=businessinsider&utm_medium=referral&feed_item_type=news
462.0,5/9/2024 4:53:31 AM,"CTLT Stock Earnings: Catalent Misses EPS, Misses Revenue for Q3 2024",InvestorPlace,/news/stocks/ctlt-stock-earnings-catalent-for-q3-of-2024-1033354148
463.0,5/9/2024 10:49:09 AM,RBC Capital Sticks to Their Hold Rating for Catalent (CTLT),TipRanks,/news/stocks/rbc-capital-sticks-to-their-hold-rating-for-catalent-ctlt-1033356502
464.0,5/10/2024 5:41:57 AM,Catalent’s Resilient Growth and Positive Outlook Reinforce Buy Rating,TipRanks,/news/stocks/catalent-s-resilient-growth-and-positive-outlook-reinforce-buy-rating-1033361960
465.0,5/19/2024 6:00:55 PM,Biopharma M&A surges year over year in Q1,Seeking Alpha,https://seekingalpha.com/news/4108148-biopharma-mergers-acquisitions-surges-year-over-year-q1?utm_source=businessinsider&utm_medium=referral&feed_item_type=news
466.0,5/24/2024 7:00:53 PM,"Catalyst Watch: Costco earnings, M&A drama, Viking ratings, and a key inflation read",Seeking Alpha,https://seekingalpha.com/news/4110251-catalyst-watch-costco-earnings-ma-drama-viking-ratings-and-a-key-inflation-read?utm_source=businessinsider&utm_medium=referral&feed_item_type=news
467.0,5/29/2024 2:18:39 PM,Catalent shareholders approve acquisition by Novo Holdings,Seeking Alpha,https://seekingalpha.com/news/4111157-catalent-shareholders-approve-acquisition-by-novo-holdings?utm_source=businessinsider&utm_medium=referral&feed_item_type=news
468.0,5/29/2024 3:32:54 PM,Catalent Stockholders Approve Deal To Be Acquired By Novo Holdings ,RTTNews,/news/stocks/catalent-stockholders-approve-deal-to-be-acquired-by-novo-holdings-1033431867
469.0,6/10/2024 10:40:20 AM,"Analysts Offer Insights on Healthcare Companies: Relay Therapeutics (RLAY), Catalent (CTLT) and Pediatrix Medical Group (MD)",TipRanks,/news/stocks/analysts-offer-insights-on-healthcare-companies-relay-therapeutics-rlay-catalent-ctlt-and-pediatrix-medical-group-md-1033465706
470.0,6/21/2024 2:03:58 PM,Catalent gains after Sarepta's Elevidys gets label expansion,Seeking Alpha,https://seekingalpha.com/news/4117940-catalent-gains-after-sareptas-elevidys-gets-label-expansion?utm_source=businessinsider&utm_medium=referral&feed_item_type=news
471.0,6/21/2024 7:52:18 PM,"Sarepta's Expanded Approval Unlikely To Influence Novo Holdings' Acquisition of Catalent, But Provides Investor Protection Amid Uncertainty",Benzinga,/news/stocks/sarepta-s-expanded-approval-unlikely-to-influence-novo-holdings-acquisition-of-catalent-but-provides-investor-protection-amid-uncertainty-1033497030
472.0,6/26/2024 1:10:26 PM,Sarepta cut to Neutral at Citi on risks to valuation,Seeking Alpha,https://seekingalpha.com/news/4119494-sarepta-stock-downgraded-citi-valuation?utm_source=businessinsider&utm_medium=referral&feed_item_type=news
473.0,6/28/2024 9:31:31 AM,Barclays Reaffirms Their Hold Rating on Catalent (CTLT),TipRanks,/news/stocks/barclays-reaffirms-their-hold-rating-on-catalent-ctlt-1033514879
474.0,7/11/2024 10:40:19 AM,Analysts Conflicted on These Healthcare Names: Lantheus (LNTH) and Catalent (CTLT),TipRanks,/news/stocks/analysts-conflicted-on-these-healthcare-names-lantheus-lnth-and-catalent-ctlt-1033547229
475.0,7/17/2024 5:42:41 PM,Catalent Expands Its Facility Capabilities in Germany,Benzinga,/news/stocks/catalent-expands-its-facility-capabilities-in-germany-1033564798
476.0,8/21/2024 7:32:46 PM,CDMO executive says Novo purchase of Catalent may help competition - CTFN,Seeking Alpha,https://seekingalpha.com/news/4142515-cdmo-executive-says-novo-purchase-of-catalent-may-help-competition-ctfn?utm_source=businessinsider&utm_medium=referral&feed_item_type=news
477.0,8/29/2024 11:37:24 AM,"Catalent Non-GAAP EPS of $0.65 beats by $0.09, revenue of $1.3B beats by $60M",Seeking Alpha,https://seekingalpha.com/news/4145009-catalent-non-gaap-eps-of-0_65-beats-0_09-revenue-of-1_3b-beats-60m?utm_source=businessinsider&utm_medium=referral&feed_item_type=news
478.0,8/29/2024 1:39:46 PM,Catalent Inc. Q4 Earnings Summary ,RTTNews,/news/stocks/catalent-inc-q4-earnings-summary-1033732359
479.0,8/29/2024 3:57:10 PM,Catalent ends FY24 on a strong note ahead of Novo buyout,Seeking Alpha,https://seekingalpha.com/news/4145154-catalent-stock-gains-q4-ahead-novo-deal?utm_source=businessinsider&utm_medium=referral&feed_item_type=news
480.0,8/30/2024 8:57:49 PM,Catalent delays 10-K filing,Seeking Alpha,https://seekingalpha.com/news/4145649-catalent-delays-10-k-filing?utm_source=businessinsider&utm_medium=referral&feed_item_type=news
481.0,9/14/2024 7:37:59 PM,J&J leads H1 healthcare deals as Big Pharma dealmaking returns: report,Seeking Alpha,https://seekingalpha.com/news/4149797-jj-leads-h1-2024-healthcare-dealmaking?utm_source=businessinsider&utm_medium=referral&feed_item_type=news
482.0,9/24/2024 8:35:51 AM,Hold Rating on Catalent Amid Deal Uncertainties and Conservative Financial Outlook,TipRanks,/news/stocks/hold-rating-on-catalent-amid-deal-uncertainties-and-conservative-financial-outlook-1033793233
483.0,9/24/2024 8:09:59 PM,Catalent cut to neutral at Baird as analyst unable to find valuation in a deal break,Seeking Alpha,https://seekingalpha.com/news/4152871-catalent-cut-to-neutral-at-baird-as-analyst-unable-to-find-valuation-in-a-deal-break?utm_source=businessinsider&utm_medium=referral&feed_item_type=news
484.0,10/3/2024 6:40:10 PM,Is Hims & Hers rally at risk as GLP-1 shortages ease?,Seeking Alpha,https://seekingalpha.com/news/4156219-can-hims-hers-stock-rally-glp-1-shortages?utm_source=businessinsider&utm_medium=referral&feed_item_type=news
485.0,10/4/2024 11:03:34 AM,Thermo Fisher plant making Astra/ Sanofi RSV drug reportedly breached FDA rules,Seeking Alpha,https://seekingalpha.com/news/4156382-thermo-fisher-stock-slips-greenville-plant?utm_source=businessinsider&utm_medium=referral&feed_item_type=news
486.0,10/10/2024 3:26:53 PM,Sen. Elizabeth Warren wants FTC to scrutinize Novo Nordisk deal for Catalent,Seeking Alpha,https://seekingalpha.com/news/4157626-sen-elizabeth-warrens-wants-ftc-to-scrutinize-novo-nordisk-deal-for-catalent?utm_source=businessinsider&utm_medium=referral&feed_item_type=news
487.0,10/14/2024 10:08:37 AM,Catalent to sell Somerset oral solids facility,Seeking Alpha,https://seekingalpha.com/news/4158138-catalent-to-sell-somerset-oral-solids-facility?utm_source=businessinsider&utm_medium=referral&feed_item_type=news
488.0,10/14/2024 12:25:20 PM,"Catalent To Sell Oral Solids Development Facility In Somerset, NJ To Ardena ",RTTNews,/news/stocks/catalent-to-sell-oral-solids-development-facility-in-somerset-nj-to-ardena-1033842420
489.0,10/17/2024 7:30:03 PM,"Consumer, labor groups urge FTC to block Catalent sale to Novo Holdings - report",Seeking Alpha,https://seekingalpha.com/news/4172071-consumer-labor-groups-urge-ftc-to-block-catalent-sale-to-novo-nordisk-report?utm_source=businessinsider&utm_medium=referral&feed_item_type=news
490.0,10/21/2024 11:11:04 AM,Catalent issues letter to customers regarding acquisition by Novo Holdings,TipRanks,/news/stocks/catalent-issues-letter-to-customers-regarding-acquisition-by-novo-holdings-1033864936
491.0,10/21/2024 11:26:59 AM,Catalent’s Maselli to continue as CEO post Novo Holdings deal close,Seeking Alpha,https://seekingalpha.com/news/4182688-catalents-maselli-to-continue-as-ceo-post-novo-holdings-deal-close?utm_source=businessinsider&utm_medium=referral&feed_item_type=news
492.0,10/21/2024 2:04:32 PM,Catalent Issues Open Letter To Customers; To Operate As Full-service CDMO Under Novo ,RTTNews,/news/stocks/catalent-issues-open-letter-to-customers-to-operate-as-full-service-cdmo-under-novo-1033864014
493.0,10/23/2024 4:26:42 PM,Roche CEO says antitrust regulators should block Catalent sale to Novo Holdings (update),Seeking Alpha,https://seekingalpha.com/news/4195690-roche-ceo-says-antitrust-regulators-should-block-catalent-sale-to-novo-foundation?utm_source=businessinsider&utm_medium=referral&feed_item_type=news
494.0,11/4/2024 3:10:03 PM,Novo Holdings' planned $16.5B acquisition of Catalent gets EU inquiry,Seeking Alpha,https://seekingalpha.com/news/4242646-novo-holdings-planned-165b-planned-acquisitions-of-catalent-gets-eu-inquiry?utm_source=businessinsider&utm_medium=referral&feed_item_type=news
495.0,11/5/2024 12:10:37 PM,"Catalent reports Q1 EPS (13c), consensus 5c",TipRanks,/news/stocks/catalent-reports-q1-eps-13c-consensus-5c-1033952737
496.0,11/5/2024 12:25:50 PM,"Catalent GAAP EPS of -$0.71, revenue of $1.02B",Seeking Alpha,https://seekingalpha.com/news/4247575-catalent-gaap-eps-of-0_71-revenue-of-1_02b?utm_source=businessinsider&utm_medium=referral&feed_item_type=news
497.0,11/5/2024 1:09:08 PM,Catalent Inc. Q1 Loss Narrows ,RTTNews,/news/stocks/catalent-inc-q1-loss-narrows-1033951097
498.0,11/6/2024 4:20:45 AM,Catalent Inc. Reports Q1 Fiscal 2025 Results,TipRanks,/news/stocks/catalent-inc-reports-q1-fiscal-2025-results-1033958852
499.0,11/6/2024 1:17:18 PM,Catalent’s Biologics Underperformance and PCH Stability Lead to Hold Rating,TipRanks,/news/stocks/catalent-s-biologics-underperformance-and-pch-stability-lead-to-hold-rating-1033962774
500.0,11/8/2024 11:20:59 AM,"Analysts Have Conflicting Sentiments on These Healthcare Companies: Catalent (CTLT), Moderna (MRNA) and HCA Healthcare (HCA)",TipRanks,/news/stocks/analysts-have-conflicting-sentiments-on-these-healthcare-companies-catalent-ctlt-moderna-mrna-and-hca-healthcare-hca-1033982242
501.0,11/13/2024 8:31:08 PM,"EU regulators seek info from rivals, customers in Catalent sale to Novo Holdings - Reuters",Seeking Alpha,https://seekingalpha.com/news/4286880-eu-regulators-see-info-from-rivals-customers-in-catalents-sale-to-novo-holdings?utm_source=businessinsider&utm_medium=referral&feed_item_type=news
502.0,11/22/2024 5:34:18 PM,Catalent gains on reports it's likely to be granted EU approval for Novo Holdings deal (update),Seeking Alpha,https://seekingalpha.com/news/4322149-catalent-gains-on-report-its-likely-to-be-granted-eu-approval-for-novo-holdings-deal?utm_source=businessinsider&utm_medium=referral&feed_item_type=news
503.0,11/22/2024 7:25:08 PM,"Novo slated to win EU approval for Catalent takeover, Reuters says",TipRanks,/news/stocks/novo-slated-to-win-eu-approval-for-catalent-takeover-reuters-says-1034056807
504.0,11/29/2024 5:00:00 PM,"Catalyst Watch: November jobs, OPEC+ meeting, Marvell, Salesforce earnings",Seeking Alpha,https://seekingalpha.com/news/4340728-catalyst-watch-november-jobs-report?utm_source=businessinsider&utm_medium=referral&feed_item_type=news
505.0,12/3/2024 6:35:35 PM,Catalent gains amid report buyer working on contact extensions with drugmakers,Seeking Alpha,https://seekingalpha.com/news/4360760-catalent-gains-amid-report-buyer-working-on-contact-extensions-with-drugmakers?utm_source=businessinsider&utm_medium=referral&feed_item_type=news
,12/6/2024 6:15:39 PM,EU approves Novo Holdings’ acquisition of Catalent,TipRanks,/news/stocks/eu-approves-novo-holdings-acquisition-of-catalent-1034109829
,12/6/2024 6:16:54 PM,"Catalent, Novo Holdings receive EU unconditional approval for transaction",TipRanks,/news/stocks/catalent-novo-holdings-receive-eu-unconditional-approval-for-transaction-1034109825
,12/6/2024 6:22:39 PM,Catalent wins EU approval for planned $16.5B sale to Novo Holdings,Seeking Alpha,https://seekingalpha.com/news/4372146-catalent-wins-eu-approval-for-planned-165b-sale-to-novo-holdings?utm_source=businessinsider&utm_medium=referral&feed_item_type=news
,12/11/2024 6:54:23 PM,Catalent gains after report sale to Novo Holdings could close soon,Seeking Alpha,https://seekingalpha.com/news/4385676-catalent-gains-after-report-sale-to-novo-holding-could-close-soon?utm_source=businessinsider&utm_medium=referral&feed_item_type=news
,12/14/2024 1:25:00 PM,"Key deals for the week: Patterson, Hershey & Mondelez, AIG & Nippon and more",Seeking Alpha,https://seekingalpha.com/news/4386404-key-deals-for-the-week-patterson-hershey-mondelez-aig-nippon-agnico-eagle-and-more?utm_source=businessinsider&utm_medium=referral&feed_item_type=news
,12/14/2024 1:51:53 PM,Novo Nordisk says Catalent buyout to close soon as regulatory conditions met,Seeking Alpha,https://seekingalpha.com/news/4386562-novo-nordisk-to-close-catalent-acquisition?utm_source=businessinsider&utm_medium=referral&feed_item_type=news
,12/14/2024 7:10:09 PM,Novo says Catalent deal regulatory closing conditions fulfilled,TipRanks,/news/stocks/novo-says-catalent-deal-regulatory-closing-conditions-fulfilled-1034137571
,12/15/2024 3:05:42 AM,Catalent And Novo Holdings Complete All Regulatory Closing Conditions For Merger ,RTTNews,/news/stocks/catalent-and-novo-holdings-complete-all-regulatory-closing-conditions-for-merger-1034137628
,12/16/2024 6:05:00 PM,Moderna remains the most shorted among S&P 500 healthcare stocks in November,Seeking Alpha,https://seekingalpha.com/news/4386556-moderna-remains-the-most-shorted-among-sp-500-healthcare-stocks-in-november?utm_source=businessinsider&utm_medium=referral&feed_item_type=news
,12/18/2024 3:07:00 PM,Most shorted S&P 500 stocks in November,Seeking Alpha,https://seekingalpha.com/news/4387564-most-shorted-sp-500-stocks-in-november?utm_source=businessinsider&utm_medium=referral&feed_item_type=news
,12/18/2024 3:22:21 PM,Catalent Acquired by Novo Holdings in $16.5 Billion Deal,TipRanks,/news/stocks/catalent-acquired-by-novo-holdings-in-16-5-billion-deal-1034152749
,12/18/2024 3:40:15 PM,Novo Holdings completes purchase of Catalent,Seeking Alpha,https://seekingalpha.com/news/4387713-novo-holdings-completes-purchase-of-catalent?utm_source=businessinsider&utm_medium=referral&feed_item_type=news
,12/18/2024 5:02:02 PM,Novo Holdings Acquires Catalent In $16.5 Bln Cash Deal ,RTTNews,/news/stocks/novo-holdings-acquires-catalent-in-16-5-bln-cash-deal-1034152010
,12/18/2024 10:20:35 PM,Lennox to replace Catalent in S&P 500 at open on 12/23,TipRanks,/news/stocks/lennox-to-replace-catalent-in-s-p-500-at-open-on-12-23-1034153653
